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During clotting under flow, platelets bind and activate on collagen and release autocrinic factors such ADP
and thromboxane, while tissue factor (TF) on the damaged wall leads to localized thrombin generation.
Toward patient-specific simulation of thrombosis, a multiscale approach was developed to account for:
platelet signaling (neural network trained by pairwise agonist scanning, PAS-NN), platelet positions (lattice
kinetic Monte Carlo, LKMC), wall-generated thrombin and platelet-released ADP/thromboxane convection-
diffusion (PDE), and flow over a growing clot (lattice Boltzmann). LKMC included shear-driven platelet
aggregate restructuring. The PDEs for thrombin, ADP, and thromboxane were solved by finite element
method using cell activation-driven adaptive triangular meshing. At all times, intracellular calcium was known
for each platelet by PAS-NN in response to its unique exposure to local collagen, ADP, thromboxane, and
thrombin. The model accurately predicted clot morphology and growth with time on collagen/TF surface as
compared to microfluidic blood perfusion experiments. The model also predicted the complete occlusion of
the blood channel under pressure relief settings.
Prior to occlusion, intrathrombus concentrations reached 50 nM thrombin, ~1 μM thromboxane, and ~10
μM ADP, while the wall shear rate on the rough clot peaked at ~1000-2000 sec-1. Additionally, clotting on
TF/collagen was accurately simulated for modulators of platelet cyclooxygenase-1, P2Y1, and IP-receptor.
The model was then extended to a rectangular channel with symmetric Gaussian obstacles representative of a
coronary artery with severe stenosis. The upgraded stenosis model was able to predict platelet deposition
dynamics at the post-stenotic segment corresponding to development of artery thrombosis prior to severe
myocardial infarction. The presence of stenosis conditions alters the hemodynamics of normal hemostasis,
showing a different thrombus growth mechanism. The model was able to recreate the platelet aggregation
process under the complex recirculating flow features and make reasonable prediction on the clot morphology
with flow separation. The model also detected recirculating transport dynamics for diffusible species in
response to vortex features, posing interesting questions on the interplay between biological signaling and
prevailing hemodynamics. In future work, the model will be extended to clot growth with a patient cardio-
vasculature under pulsatile flow conditions.
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ABSTRACT 
MULTISCALE MODELLING OF PLATELET AGGREGATION 
Yichen Lu 
Scott L. Diamond 
Talid R. Sinno 
During clotting under flow, platelets bind and activate on collagen and release autocrinic 
factors such ADP and thromboxane, while tissue factor (TF) on the damaged wall leads 
to localized thrombin generation. Toward patient-specific simulation of thrombosis, a 
multiscale approach was developed to account for: platelet signaling (neural network 
trained by pairwise agonist scanning, PAS-NN), platelet positions (lattice kinetic Monte 
Carlo, LKMC), wall-generated thrombin and platelet-released ADP/thromboxane 
convection-diffusion (PDE), and flow over a growing clot (lattice Boltzmann).  LKMC 
included shear-driven platelet aggregate restructuring. The PDEs for thrombin, ADP, and 
thromboxane were solved by finite element method using cell activation-driven adaptive 
triangular meshing. At all times, intracellular calcium was known for each platelet by 
PAS-NN in response to its unique exposure to local collagen, ADP, thromboxane, and 
thrombin.  The model accurately predicted clot morphology and growth with time on 
collagen/TF surface as compared to microfluidic blood perfusion experiments. The model 
also predicted the complete occlusion of the blood channel under pressure relief settings. 
Prior to occlusion, intrathrombus concentrations reached 50 nM thrombin, ~1 M 
thromboxane, and ~10 M ADP, while the wall shear rate on the rough clot peaked at 
~1000-2000 sec
-1
.  Additionally, clotting on TF/collagen was accurately simulated for 
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modulators of platelet cyclooxygenase-1, P2Y1, and IP-receptor. The model was then 
extended to a rectangular channel with symmetric Gaussian obstacles representative of a 
coronary artery with severe stenosis. The upgraded stenosis model was able to predict 
platelet deposition dynamics at the post-stenotic segment corresponding to development 
of artery thrombosis prior to severe myocardial infarction. The presence of stenosis 
conditions alters the hemodynamics of normal hemostasis, showing a different thrombus 
growth mechanism. The model was able to recreate the platelet aggregation process 
under the complex recirculating flow features and make reasonable prediction on the clot 
morphology with flow separation. The model also detected recirculating transport 
dynamics for diffusible species in response to vortex features, posing interesting 
questions on the interplay between biological signaling and prevailing hemodynamics. In 
future work, the model will be extended to clot growth with a patient cardio-vasculature 
under pulsatile flow conditions.    
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Chapter 1 : Introduction 
 
Systems biology is an emerging approach that uses modern computational and 
mathematical models to simulate complex biological systems. [1] One of the major 
principles of systems biology is its holism which aims to decipher the complexity of 
biological systems from the basic understanding of individual living organisms and 
through the incorporation of within different interacting subcomponents. This approach 
has found its place in the science of human health and environmental sustainability which 
will require the understanding of basic mechanisms at each individual level to obtain a 
holistic picture of the overall problem. [2] Due to the complexity of biological systems, it 
is often necessary to integrate many scientific disciplines such as biology, computer 
science, physics, bioinformatics and many others. In order to make meaningful prediction 
on how systems vary under various conditions, it is often a collaborative effort from 
researchers with cross-disciplinary backgrounds. In the field of multicellular biology, a 
system biology approach will often involve the study of how cellular components 
produce certain cellular phenotypes, how molecules contribute to the occurrence of 
certain process, how tissues and organs perform certain function. Adopting principles of 
systems biology, many computational models have been established to gain insight into 
detailed disease mechanisms to identify potential pharmacological targets and quantify 
the efficacy of drug treatment. In addition to conventional clinical studies, computational 
models not only serve as a complementary route with less financial inputs but also enable 
exploration into realms inaccessible by experimental approaches. The flexibility of 
numerical models can also allow the creation of patient-specific therapies that can adjust 
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the drug dosage based on the genetic fingerprints of certain stratification of patient 
groups. 
 The nature of systems biology requires the understanding biological functions on 
multiple time and length scales. The typical modelling methods expand a range of time 
scales from nanoseconds to minutes and involve different modelling approaches such as 
quantum mechanisms, molecular dynamics, mesoscale or nanoscale models and 
continuum formulation. The length scale under study includes levels from small cellular 
components to large organs. Due to the limitation of the computational resources and 
quantitative measurement, a fully resolved molecular simulation encompassing all minute 
details is almost an impossible task. One could even argue the necessity of such models 
since the point of interest will generally lie on a macroscopic level. Taking the problem 
of hemostasis for example, the underlying biological networks typically involve 
thousands of species with reactions occurring on the ligand level within nanoseconds. An 
efficient coarse-grained representation of the cellular mechanisms has to be adopted to 
study the process of thrombus formation that occurs at much larger time and length scales. 
Understanding specific features and making reasonable prediction on certain biological 
processes is the ultimate goal rather than resolving the minute details of the intermediate 
components. This gives rise to one imminent theme of all multiscale models, which is 
how one can identify essential components that contribute to certain biological function 
and extract meaningful information based on theoretical principles, experimental 
measurement and numerical approximation.  Another essential topic in model 
development is the coupling or crosstalk of different numerical methods to be applied at 
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different levels. This gives rise to a lot of interesting challenges in model integration and 
algorithm optimization. More importantly, numerical models can never be built without 
essential knowledge derived from experiments. Experimental data typical serve as 
guidance in identifying crucial mechanisms and important subcomponents. The 
experimental measure will be essential for calibration and validation of models.  Models 
on the other hand can be extremely usefully in generating hypothesis and predicting 
behaviors outside the experimental dataset, which adds to the understanding of the 
biological principles even further. 
 One interesting research topic that attracts enormous attention in the scientific 
community is the problem of platelet aggregation. Platelets also called thrombocytes are 
a small discoid-shaped blood component whose major function is to promote hemostasis 
by forming a stable blood clot to prevent extra blood loss. After the injury of vessel wall, 
platelets become adhered to the subendothelial collagen, thereby initiating the process of 
thrombus formation. The process of platelet aggregation is the body’s natural response to 
minimize hemorrhage and restore the integrity of blood vessels. Platelet activation 
involves many pro- and anti- clotting agonists that work synergistically to facilitate the 
signaling between individual cells and other clotting media. Furthermore, the transport of 
platelets within the blood vessels is largely governed by the fluid dynamics of blood flow 
and the presence of larger cellar components like red-blood cells (RBC). The fluid can 
also affect the biological mechanisms related to platelet binding through the effect of 
local shear conditions. The complex problem of platelet aggregation is an interesting mix 
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of biological mechanisms and physical forces that naturally call for a multiscale 
modelling approach.  
The rest of the thesis will be focused on building a multiscale platelet aggregation 
model to simulate the process of clot formation under blood flow. The following sections 
in Chapter 1 will provide a general overview of the background for platelet aggregation 
and blood coagulation with an emphasis on model development. Chapter 2 will discuss a 
number of numerical techniques for building the multiscale model. Chapter 3 will focus 
on the detailed description of the multi-component lattice Kinetic Monte Carlo (LKMC) 
model to simulate the stochastic motion and reaction of platelets within a microfluidic 
channel. In Chapter 4, the model will be extended to a representative coronary artery with 
stenotic geometry. Finally, Chapter 5 will discuss the potential future application and 
improvement of the model. 
1.1 Background of hemostasis and thrombosis 
Hemostasis refers to the rapid response from the hemostatic system to prevent 
excessive bleeding upon tissue injury. [3] The endothelium served as an anticoagulant 
surface that tightly regulates the function of blood in its fluid phase. During the event of 
external injury or other pathological conditions, the subendothelium matrix is damaged 
and starts to interact with flowing blood. The exposed collagen and von Willebrand 
Factor (vWF) serve as two major physiological activators for platelet function, creating 
the initial platform to recruit free-flowing platelets in their quiescent phase. The attached 
platelets undergo complex biological reactions involving many receptors and ligands and 
reach critical levels of activation. Activated platelets transform from biconcave disks to 
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fully spread cells and start to release autocrine activators such as ADP and thromboxane 
(TXA2). [4] These diffusive secondary pro-coagulant agonists play a significant role in 
biological signaling by recruiting quiescent and activating new platelets to the injury site. 
Apart from collagen and vWF, the exposed tissue factor initiates the coagulation cascade, 
producing an important serine protease known as thrombin. Thrombin executes several 
critical reactions involving cleavage of fibrinogen to insoluble fibrin [5], cleavage of 
PAR1 and PAR4 to initiate platelet activation [6], feedback activation of zymogens such 
as factor XI, VIII and V. [5] 
 Thrombosis refers to pathological clot formation, causing complete occlusion of 
blood vessels leading to life-threatening events of myocardial infarction, stroke and 
venous thromboembolism. In fact, acute atrial thrombosis is the responsible for more than 
90% of myocardial infarction and stokes, which are the two major causes of death in the 
western world. [7] The treatment of arterial thrombosis is generally realized by inhibition 
of platelet aggregation through many drug targets. [8] Clopidogrel blocks the receptor 
P2Y12, thereby inhibiting the activation of adenosine diphosphate. [9] Acetylsalicylic 
acid (aspirin) irreversibly inhibits COX-1 in the thromboxane A2 synthesis pathway, 
therefore inhibiting the activation of TXA2. [10] There are also intravenous (IV) drugs 
such as abciximab, eptifibatide and tirofiba that inhibit integrin αIIbβ3 primarily used to 
prevent acute coronary events. [11] Dipyridamole (Persantine) is an oral drug that 
primarily used for secondary prevention of stroke and transient ischemic attack by 
inhibiting adenosine reuptake and thromboxane synthesis. [12] 
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1.2 Blood coagulation cascade 
Plasma coagulation has two initial pathways: intrinsic and extrinsic. [13] (Figure 1-1) 
The pathways are a series of reactions, in which a zymogen (inactive enzyme precursor) 
of a serine protease and its glycoprotein co-factor are activated to become active 
components that then catalyze the next reaction in the cascade, ultimately resulting in 
cross-linked fibrin. The extrinsic pathway is mainly induced by tissue damage. The 
exposed tissue factor (TF) attracts and activates circulating factor VII(FVII) to form 
complex TF/FVIIa. The TF/FVIIa complex then activates the common pathway factor X 
(FX). The activated factor X (Xa) undergo through a series of intermediate reactions, 
ultimately transforming prothrombin to thrombin. The intrinsic pathway is mainly 
induced by exposure to anionic surfaces through activation of factor XII (FXII). Upon 
activation FXIIa converts downstream factor XI (FXI) to its activated form FXIa, which 
ultimately leads to formation of intrinsic tenase FIXa/FVIIIa. Similar to extrinsic tenase, 
FIXa/FVIIIa also act on phospholipid membranes that catalyze the formation of thrombin 
from prothrombin. [14] Thrombin generation leads to activation of factor XIII (fibrin 
stabilizing factor) which covalently links fibrin polymers and provides strength and 
stability to fibrin incorporated in platelet plug. [15]  
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Figure 1-1: Schematic of simplified cascades in the blood coagulation cascade 
 
1.3 Microfluidic models of thrombosis in flow 
The in vivo models for thrombosis typically have a variety of vessel geometries, injury 
sizes, and flow conditions, adding the difficulty for quantification and characterization. 
The complexity of in vivo settings arises from single protein and protein ensemble 
mechanics, single cell biomechanics, dense suspensions of cells in time-dependent flows, 
and cellular mechanobiological response to forces transmitted by and through fluids and 
tissues. [16] Microfluidics can serve as a good substitute that can recreate biochemical 
and biological complexity under the dynamic conditions of the vasculature. 
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 Recently, microfluidic devices have been fabricated [16-19] to generate an open 
reacting reservoir with blood being directed into the microfluidic channels. Strips of 
collagen are laid perpendicular to the microfluidic channels to mimic a focal injury. The 
8-channel microfluidic devices allow for generation of large datasets where different 
conditions can be tested in different channels for one single experiment. Direct imaging 
of platelet deposition can be done in the microfluidic channels with fluorescence 
microscopy, and morphological information can also be extracted. [20] For studies of 
thrombin generation, tissue factors can also be affixed to the surface of the microfluidic 
channel. Colace et al. [21] linked TF-incorporated lipid liposomes to collagen surface by 
iotinavidin interaction to create prothrombotic surfaces mimicking in vivo injuries. Local 
hemodynamic conditions can be perfectly replicated among 8 channels to quantify 
thrombus formation dynamics with and without fibrin deposition. The high-throughput 
nature of the device has also enabled the manipulation of various drug conditions and has 
been applied to study patients with congenital bleeding disorders. [22] 
1.4 Numerical models of platelet aggregation and blood coagulation 
Models for platelet signaling 
Kinetic modelling of platelet signaling mechanisms has long been pursued with the aim 
of better understanding of the hemostatic process. One approach is take the mechanistic 
route by building a fully established reaction network involving important agonists and 
other intermediate reactants, converging to the intracellular calcium level. Purvis et al. 
developed an ordinary differential equation (ODE) system of platelet activation model in 
response to ADP stimulation of P2Y1. [23,24] The work demonstrated the importance of 
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both steady-state and dynamical information in determining the platelet activation 
function. A more recent effort is to use artificial neural network to characterize the 
signaling pathways. Rather than directly estimating the kinetic parameters and reaction 
mechanisms, the neural network (NN) predicts the intracellular calcium response by 
creating artificial network architecture. The NN is mainly data-driven and focuses on the 
final output without resolving the intermediate processes. Chatterjee et al. used high-
throughput, pairwise agonist scanning method to obtain calcium response to binary 
simulation of agonists at different concentration levels. The NN was then be trained with 
carefully designed parameterized architecture and validated with similar datasets. The 
NN allows for patient-specific prediction on the platelet signaling.[25] Later, Lee el al. 
further expanded the NN model to 6 agonists, including thrombin. The work 
characterized an averaged calcium response function based on training data collected 
from 10 healthy donors. One thing to note is that all these models assumed the 
homogeneous well-mixed condition where only prediction on the averaged calcium 
response. [26] 
Models for coagulation cascade 
One of the most famous models for blood coagulation is the ODE model proposed by 
Hockin et al. [27] The Hockin model captures all phases leading to thrombin production 
stimulated by tissue factors. Kuharsky and Fogelson proposed a pseudo ODE model for 
thrombin generation by considering the effect of flow. They designed a separated 
reaction zone in a blood vessel and proposed an effective mass transfer coefficient that 
characterized the overall effect of flow. [28] Chatterjee et al. expended the Hockin model 
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to include the activation state of platelets. The activated platelet state is used as a 
modulator for reaction rates within the coagulation cascade. The development of 
concentration of the coagulation factors was predicted and validated against 
combinatorial high-throughput experiment. [29] The goal of these ODE models aims to 
obtain thrombin generation function in response to different levels of tissue factor 
simulation. Again, the assumption of the ODE formulation is reliant on all species being 
homogenous within the system. The predicted thrombin generation curve typically has an 
initiation phase followed by a decaying stage as thrombin inhibition takes place. 
Models for particle motion under flow 
Particle motion in a flowing fluid depends on the hydrodynamic interactions between the 
particles. Models that incorporate hydrodynamic interactions include dissipative particle 
dynamics (DPD) [30-32], lattice Boltzmann (LB) [33-35], and direct solution of the 
coupled fluid momentum and particle motion equations such as the arbitrary Eulerian-
Langrangian method [36].  DPD lumps packets of fluid into discrete particles subject to 
random and viscous forces that effectively solves the Navier-Stokes equation. Lattice 
Boltzmann assumed a distribution function of particles satisfying macroscopic constraints 
that also solve the flow equation effectively. To account for the two-way interaction 
between flow and particles, the scale of simulation is very limited due to computational 
overhead incurred by fluid-particle coupling. An alternative is to only consider the way 
interaction that is flow is unperturbed by the particle motion while the fluid particle is 
perturbed by the background. Such assumption is valid when the size of the particle is 
relatively small and the flow is relatively fast to be unperturbed by the presence of 
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particles. Such models include dissipative particle dynamic (DPD) model [30], the 
cellular Potts model [37], the lattice Kinetic Monte Carlo model with convection[38,39]. 
Flamm extended the limit of traditional kinetic Monte Carlo method to include the effect 
of convective field. Later the model was further extended to include aggregation reaction. 
These methods can cover a much longer time scale, thus are well-suited for simulations 
of platelet motion under flow. 
Models for particle margination 
Platelet margination refers to the process of small platelets being pushed to the vessels of 
other large particles such as red blood cells under hydrodynamics forces. Platelets 
experience a shear-induced diffusion (SID) which describes the motion of particles in a 
flowing suspension due to collision with large particles [40]. The collisions are caused by 
gradients in particle density and suspending fluid viscosity that lead to the motion of 
particles in the flow direction and perpendicular to it. It was found the effective 
diffusivity from solute transport model with red blood cells was O(10
-7
) cm
2
/s [41], while 
the diffusion coefficient estimated from the Stokes-Einstein equation was O(10
-9
) cm
2
/s. 
This indicates the classical Brownian motion can be neglected and the platelets motion 
results mostly from their interaction with RBCs or the perturbation of suspending fluid by 
large cellular entities.[42]  
It is well-known that platelets have a nonuniform radial distribution. Adding a constant 
effective diffusion doesn’t generate a net movement towards the vessel walls. One way to 
account for the near-wall excess of platelets is to add a biased radial contribution. An 
empirical drift model that accounts for bias in platelet motion toward the wall was 
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proposed by Eckstein and Belgacem [40]. Later Yeh proposed a spatially varying drift 
velocity determined by experimental data [43]. Chen et al. proposed a formulation for the 
radial drift by considering the effective radii of both RBC and platelet and also the RBC 
collision gradient [44].  
Fully coupled multiscale models for platelet aggregation  
To under the entire clotting process, a multiscale modelling approach has to be adopted to 
account for aspects like platelet adhesion and aggregation, blood coagulation initiated by 
tissue factor, release of secondary agonists, and platelet signaling. A fully coupled model 
will require interaction between different numerical techniques across many disciplines 
with involve spatial scales ranging from millimeters to nanometers and timescales from 
minutes to milliseconds.  
The past decade has witnessed an upsurge of new models describing the clotting process 
with fully resolved particle-fluid interaction. In the meantime, there is an occurrence of a 
wealth experimental data both from in vitro microfluidic perfusion [16,18,20] and in vitro 
injury models [45-47].  
Leiderman and Fogelson used a continuum method based on immerse boundary method 
[48] that explicitly solves the spatial-temporal variations of agonists. The Leiderman-
Fogelson model treated platelets (inactivated and activated) of continuum species and 
made prediction on thrombin generation by solving kinetics and transport of zymogens 
and enzymes.  
Xu et al. [37] used a cellular Potts model to account for platelet motion coupled with 
fluid flow. The simulation domain was characterized by occupied cell nodes and fluid 
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nodes, where the transformation between two nodes is achieved by specifying a 
Hamiltonian where a Metropolis Monte Carlo criterion was used to accept or reject any 
move. 
Flamm et al. [49] developed a lattice Kinetic Monte Carlo model that used kinetic Monte 
Carlo to solve platelet motion, lattice Boltzmann for fluid flow, finite element  to solve 
transport of diffusive agonists. The platelet signaling was characterized an artificial 
neural network trained from patient data. The Flamm model didn’t consider the thrombin 
generation. 
Yazdani et al. [50] developed an Eulerian-Lagrangian model to predict thrombus shape 
and growth, where motions of Lagrangian platelets were coupled with the background 
blood flow using a force coupling method. Further, platelet adhesion to the site of injury 
and to each other was modeled by a shear-dependent Morse potential, which was 
calibrated with experimental data for different shear conditions. The model also 
compared thrombus formation dynamics for stenotic channel with pathological shear 
conditions.  
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Chapter 2 : Numerical Methods 
 
This chapter discusses different numerical methods and their applications in the 
simulation of the platelet aggregation process. Detailed implementation guidelines about 
the kinetic Monte Carlo (KMC), the lattice Boltzmann (LB), and the finite element 
method (FEM) and neural network (NN) are presented within the following sections.  
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2.1 Kinetic Monte Carlo method for stochastic systems 
Kinetic Monte Carlo (kMC) algorithm is an extension to the classic Metropolis 
Monte Carlo methods where the evolution of systems is governed by a series of randomly 
sampled events that satisfy the desired overall kinetics. KMC aims to evolve the system 
dynamically from state to state by pre-calculating all possible transition rates for the 
current configuration with time increments congruent with the underlying microscopic 
kinetics of the system. Unlike Molecular Dynamics (MD) which can typically reproduce 
the dynamics of the system of time scale less than 10 nanoseconds, kMC simulations can 
usually reach seconds and well beyond. [51]  
A typical simulation has three major steps: 
1. Choose next event based on pre-calculated rate information  
2. Update the system clock according to the specific event 
3. Update rate catalog following event execution 
The wait time after one event is being executed can be calculated from the 
assumption that all events are independent Poisson processes. More specifically, let 
 ,P    be the joint distribution of the next event being time μ and occurring in the time 
interval  ,t t  . Then for a Poisson process,  ,P t    . The probability that 
none of the N events occurs in the time interval    0 exp totP t t      ,t t   is 
 0 totalP t    , where 
1
N
total i
i
    . The probability of that the next event being 
executed is of type   and occurs in the time interval  ,t t t      is  
 exp total t    .  
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The wait time for the next event for N independent Poisson processes is 
 ln
total
u
  

 , 
where u  is a random number drawn from the unit interval, with 
1
average
total
 

 . And the 
probability of choosing event μ as the next event is 
total
P





 .  
2.1.1 System update method  
  There are three typical system update method based on the kMC probability 
schemes. Gillespie first proposed direct method where for each step, a specific event was 
determined by the random number u and by locating the exact event number μ satisfying  
1
1 1
i i
i itotal total
u
 
 
 
 
 
   . The overall complexity is O(N) for both selection and time 
update. Gillespie then proposed an improved first reaction method by directly sampling 
random wait times for all events. More specifically, for each event i, a wait time is 
randomly generated with 
 ln i
i
i
u
  

 . As Poisson processes are memoryless, it is only 
the wait times for the current selected event and all possible newly created events that 
needs updating, therefore reducing the time complexity for system update to O(1). 
Gibson and Bruck [52] proposed the next reaction method which further reduced the time 
complexity of event selection to O(1) as well. The idea is to track the putative absolute 
time at which an event occurs and always execute the time with the least finish time. 
Most of the computational cost now lies in sorting the absolute finishing times for all 
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events which can be obtained with O(log(N)) with efficient sorting algorithms such as 
skip list, quick sort, etc.  
2.1.2 Lattice Kinetic Monte Carlo for diffusion and convection 
Flamm, et al proposed a lattice kinetic Monte Carlo algorithm that simulates the 
trajectories of tracer particle in the fluid undergoing diffusive and convective motion. [39] 
To implement LKMC, the important input is the rate catalog summarizing probabilities 
of all possible events. The simulation domain is typically discretized with uniform lattice 
spacing in each direction of motion (Figure 2-1A, B). The reaction rate for a diffusive 
move from one lattice site to its nearest neighbor is defined as 
2d
D
h
  , where h is the 
lattice spacing and D is isotropic diffusivity . The rate of a convective motion in the 
direction i is given by ic
v
h
  . The combined diffusive and convective motion rates in 
the direction i is 
2
i
motion
v D
h h
    (Figure 2-1C). In the case of blockage, this Simplest 
Biasing Algorithm (SBA) will cause a sampling bias for the blocked particle where the 
propensity for potential motion in the absence of obstacle is simply ignored. To correctly 
account for blocked motion rate, Pass Forward Algorithm (PFA) is proposed which 
passes the potential motion rates for the blocked particles to the front free particle, 
thereby accelerating the motion rate for the connected unblocked particle. The PFA 
scheme under a typically 2D configuration is shown in (Figure 2-2). 
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Figure 2-1: Illustration of the KMC algorithm 
(a) Two-dimensional rectangular domain discretized with lattice spacing hx and hy. The flow field, 
represented by v, can be any externally applied flow. (b) Blowup of a region of high 
concentration from panel (a) showing the blocking that occurs with multiple particles. (c) 
Transition rates for an isolated particle with flow toward the right. 
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Figure 2-2: Illustration of the Pass Forward Algorithm 
Arrows denote the passing of convective rates to the front of connected chains defined in the 
directions of the components of a generalized velocity v. The motion rate of the blocked particle 
is passed to the next particle in that direction. 
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The lattice spacing is typically not restricted the size of particle. A particle can take up 
several lattices and we can define the radial resolution 
R
h
    as the ratio of the particle 
radius R and lattice spacing h. (Figure 2-3) It has been shown that in the low 
concentration limit, the algorithmic diffusive error due to discretization is 
2
err
vh
D   The 
numerical error Peclet number is defined as 2LKMC
err
vR
Pe
D
  .  
 
 
Figure 2-3: Example of discretized spherical platelets  
A platelet of radius R is placed on a uniform grip of size h with radial resolution 
R
h
   . 
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2.2 Lattice Boltzmann method for perturbed flow 
The lattice Boltzmann (LB) method is a useful computational fluid dynamics 
method to solve complex problems involving interfacial dynamics and complex 
boundaries. Unlike conventional numerical schemes that solve the macroscopic 
continuum fluid equations, the lattice Boltzmann method is based on mesoscopic 
approximation of the kinetics of the underlying cellular distribution. Originated from 
lattice gas automata, LB can be best reckoned as a special finite difference scheme that 
solves the kinetic equation for the velocity distribution function. The evolution of the 
particle distribution function is governed by the particular streaming and collision step 
which replicates specific macroscopic constraints. The macroscopic entities such as 
velocity, pressure, etc. can be deduced from the distribution function, which allows 
flexibility in transient simulation as well. One of the major advantages of LB is its 
flexibility in handling complex geometries such as rough thrombus surface where the 
solid interface is typically modelled as discretized obstacles following specific boundary 
conditions. The discretized nature of the LB also creates major opportunities for massive 
parallelism. 
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2.2.1 Streaming and collision propagator  
Almost all incompressible fluid problems can be reduced to solving the Navier-
Stokes equation with continuity constraints where the velocity field v satisfies: 
2 2
0
P
t


     

 
v
v v v
v
 ,  (2-1)  
where  is the kinematic viscosity of the fluid. 
 
The simulation domain is discretized to uniform square lattices where a unit cell contains 
several lattice directions.  
 
Figure 2-4: D2Q9 unit node including 8 nearest neighbors and itself 
 
For a D2Q9 configuration (Figure 2-4), the system is consisted of uniform square lattices 
where each nodes contains distribution function for the node itself and its eight nearest 
neighbors. The physical properties such as velocity, time, lattice spacing needs to be 
scaled to LB units such that the velocity magnitudes (LB velocity / LB time unit) are 
defined as  
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  (2-2) 
and 1x y    for lattice space, 1t   for time step. The probability distribution of 
particle at a node position x  at time t with velocity ie is denoted as  ,if tx . The LB 
equations begin from a discrete kinetic equation for particle distribution function: 
      , , , , 0, 1, 2, ... ,8i i if t t f t f x t i    ix e x             (2-3) 
The density and momentum are defined as moments of the distribution function 
satisfying: 
,i i
i i
f f    iv e                 (2-4) 
and conservation of mass and momentum: 
0, 0i i
i i
     ie                 (2-5)            
One popular propagator known as the Bhatnaar, Gross and Krook (BGK) operator [53] 
involving single relaxation parameter   is defined as: 
    
1
, ,eqi i if t f t

   x x ,    (2-6) 
The resulting algorithm is iterated between two steps: propagation and collision until the 
operator reached equilibrium for steady-state problems. For transient problems, the 
collision step evolves the distribution function by one lattice unit in time domain until the 
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equivalent solution time is reached. The exact formulation for D2Q9 is summarized as 
follows: 
The equilibrium distribution is  
   
229 3
1 3
2 2
eq
i if w 
 
      
 
i i
e v e v v      (2-7) 
where the weights are  
0 1 2 3 4 5 6 7 8
4 1 1
, ,
9 9 36
w w w w w w w w w           (2-8) 
Propagation step: 
   * , ,i if t f t ix e x       (2-9) 
The BGK formula for collision: 
        
1
, , , ,eqi i i if t t f t f t f t

      ix e x x x   (2-10) 
where  * ,eqif tx  is the post-propagation/pre-collision equilibrium distribution and the 
relaxation parameter   (typically between 0.5 to 2.0) is related to kinetic viscosity in LB 
unit 
6 1
2
LB

 . 
2.2.2 Boundary conditions  
The flexibility of boundary condition handling allows direct treatment of no-slip 
conditions, making LB a good choice for simulating flow under complex obstacles. 
Bounce-back schemes are typically applied to the wall nodes. He et al [53] proposed a 
special bounce-back condition for non-equilibrium distribution calibration, which one of 
the mostly widely used schemes. Pressure conditions can also be easily implemented by 
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setting a constraint on the density function rather than the velocity component usually at 
the both the inlet and outlet.  For a fully discretized system where the boundary nodes 
coincide with the obstacle, usually some variants of the classic bounce-back rules are 
applied. For more complicated cases where hierarchical gridding schemes are applied, the 
unaligned nodal structures call for special treatment where half bounce-back rules or 
curve boundary-conditions [54] are utilized. In the case of advanced flow propagator 
which allows multiple relaxation parameters, boundary conditions need to be changed 
accordingly to avoid unphysical representation in distribution function with more than 
relaxation times. 
2.3 Finite element method for diffusive agonist transport 
Finite element method (FEM) is a simple yet powerful method to solve numerical 
partial differential equations relating to the transport of reactive-diffusive agonists under 
complex flow conditions. The governing equation solving the concentration field C  for a 
soluble species known as the convective-diffusion-reaction equations is given by 
2C C D C R
t

    

v                (2-11) 
 
where v is velocity field of the fluid, D is the diffusion coefficient of the solute, and R is 
the generation/consumption rate for the solvent.  
The FEM solution of a PDE is obtained by approximating the dependent variables 
with piecewise nodal approximation. The simulation domain is discretized into non-
overlapping elements with basis functions. The approximated solution for concentration 
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field C pertaining to element e is 
1
ˆ
e
e
i i
i
C C

 , where ei i   is only nonzero when node 
i is adjacent to the element e. The original PDE can be reduced to simple linear matrix 
system due to the linearity in the FEM method. The weight residual for the ith node, iW  
has to be balanced for any piecewise interpolation of the basis function i . Therefore  
2
i i i i
C
W d W Cd W D Cd W Rd
t
   

      
   
v    (2-12) 
which by Green’s theorem reduces to  
 
i i
i i i i
C
d Cd
t
D Cd D C d Rd
 
   
 
  

   

        
 
  
v
n
     (2-13) 
Plug in 
1
n
j j
j
C C

 , 
1 1
1 1
n n
j j
i i j j
j j
n n
i i j j i j j i
j j
C
d C d
t
D C d D C d Rd

  
     
  
   
   

       
  
   
v
n
 (2-14) 
The reduced matrix system is given by, 

M C+ AC = b     (2-15) 
where A = K + G, b = p + r  with 
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  (2-16) 
Generally a finite difference approximation is applied to the time 
derivative
1t t
t t
 

 
C C C
 . A weighted contribution from the previous time and the 
current time is applied to the matrix A  and the vector b . 
   1 11 , 1t t t t         A A A b b b    (2-17) 
If 0  , the explicit Euler method is obtained. 1   gives the implicit Euler method, 
which is unconditionally stable. If 
1
2
  , the Crank-Nicolson method is obtained.  
2.4 Neural network 
Neural network is a computational method widely used in computer science that 
uses an artificial network structure mimicking the decision process of a biological brain. 
The primary goal of a neural network is to predict the output in response to various inputs 
by applying a highly connected network structure consisting of input nodes, hidden nodes 
and output nodes. Each neuron unit is typically connected to many others, translating the 
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activation information to the next layer and making prediction based on the overall 
additive response from other nodes.   
 
 
 
 
 
 
Figure 2-5: A simple neural network structure with p inputs and single output 
 
A naive neural network structure is shown in (Figure 2-5), which is equivalent to 
a multiple linear regression model in which the expected response y is related to the 
values of inputs  1 2, , ..., px x x x   by 
0
1
p
i i
i
y w w x

        (2-18) 
The one single processing node in this case, translates the information by simply using a 
linear combination of all different input variables with a bias term with weights left to be 
determined through an optimization process. The major step of constructing a neural 
network involves: 
1. Design the architecture of the artificial network. 
2. Propose appropriate activation and loss function. 
3. Obtain unknown weights through iterative gradient search over the parameter spaces.  
y
0w
1x
2x
px
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One of the most intriguing features of NN is its nodal structures. For many 
problems where there is insufficient information regarding the exact intermediate 
mechanisms, the structure of the underlying network can involve a trial-and-error process. 
Many complicated problems such as image recognition may require deep neural network 
structures involving multiple processing layers. Some recurrent NNs also have 
connectivity to predictions from earlier states and use a variety of feedback and control 
loops which may add difficulty in the training process. One caveat for almost all machine 
learning problems is watch for potential overfitting. Neural network is particularly prone 
to over-specification, therefore adding unnecessary complexity which both creates 
computational burdens and reduces the power of generality. Despite the elusive nature of 
the neural net, there are a number of advantages compared to other machine learning 
algorithms. [55] NNs are generally easy to train in the presence of multiple training 
algorithms. They are also able to detect all possible interaction among the predictor 
variables. In some cases, NNs can implicitly predict the complex nonlinear cross-talk 
between the intermediate variables, making them particularly useful for complex 
biological reaction networks with perplexing intermediate signaling pathways. 
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Chapter 3 Multiscale modelling of platelet aggregation 
3.1 Introduction 
Platelets play a critical role in primary hemostasis to prevent blood loss due to 
vessel injury.  Secondary hemostasis requires wall and tissue factor (TF) to activate the 
coagulation protease cascade leading to thrombin generation and subsequent fibrin 
polymerization to stabilize the clot. Unfortunately, during atherosclerotic plaque rupture 
that initiates a heart attack, flowing blood is exposed to a highly procoagulant surface 
containing tissue factor (TF).  Platelets are captured from flow and activate on collagen. 
Intracellular calcium mobilization results in integrin activation and firm arrest, dense 
granule release of ADP, activation of cycloxygenase-1 (COX1) and subsequent 
thromboxane (TXA2) synthesis, and phosphatidylserine exposure. Both ADP and 
thromboxane are autocrinic species the enhance platelet activation and are highly 
targetable by drugs (P2Y12 inhibitors and aspirin) to reduce risk.  
Thrombosis is the result of complex biological processes that occur in space and 
time and are coupled to prevailing hemodynamics that dictate cell collision rates, dilution 
of reactive species, and forces on clot ensembles.  Modeling of thrombosis has advanced 
significantly [37,48,49] as reviewed by [42,56]. The opportunity now exists to use 
patient-specific hemodynamics [57], platelet signaling models [26,29,49], and bottom-up 
models of coagulation [27,29] for multiscale simulations of thrombosis[49]. Such 
multiscale simulations can be compared and validated against direct measurements of 
clotting reactions over defined reactive surfaces and defined shear rates in microfluidic 
flows [19,20,58].    
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In prior work [49], a multi-element patient deposition model utilized a 4-agonist 
(ADP, TXA2, collagen, prostacyclin) neural network (NN) to predict platelet dynamics 
under venous and arterial shear condition in the absence of thrombin. This NN was 
trained using calcium traces obtained for all single and pairwise combinations of agonists 
at low, medium, and high concentration.  In this pairwise agonist scanning (PAS) 
experiment, ADP and mimetics for collagen, thromboxane, and prostacyclin were used to 
quantify P2Y1/P2Y12, GPVI, TP, and IP signaling, respectively, for NN training.   Along 
with NN for platelet signaling, the LKMC model utilized velocity fields from Lattice 
Boltzmann (LB) and prevailing concentration profiles obtained by finite element solution 
of convection-diffusion PDEs. Platelet motion and binding/unbinding were solved 
stochastically by the lattice Kinetic Monte Carlo method (LKMC). 
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Figure 3-1: Multiscale picture of computational modules (Lattice Boltzmann for flow field, 
Finite Element for agonist concentration, Neural Network for calcium prediction, Lattice Kinetic 
Monte Carlo for platelet motion) 
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Figure 3-2: Two-layer neural network structure with 6 inputs (ADP, CVX, thrombin, U46619, 
Iloprost, GSNO) to predict platelet calcium trace 
 
In the present study (Figure 3-1), the multiscale model has been expanded and 
refined in several important aspects: (i) the NN prediction of platelet calcium (Figure 3-2) 
was expanded to include thrombin in the PAS training set averaged over 10 healthy 
donors (50% male) [26]; (ii) the finite element mesh for solution of ADP, TXA2 and 
thrombin spatiotemporal concentrations was refined using platelet activation-driven 
adaptive meshing with triangular elements (remeshing algorithm); (iii) individual 
platelets were allowed to find the most stable nearby position of greatest bonding after 
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initial capture to the clot (remodeling algorithm); (iv) thrombin was released from the 
wall into the clot assuming a parameterized curve with initiation and decaying stages of 
clotting triggered by tissue factor; (v) flow fields were calculated for either constant flow 
rate (non-physiologic but experimentally accessible) or constant pressure-drop (full 
occlusion possible). 
The adaptive meshing algorithm allowed for efficient calculation of soluble 
species transport with growing platelet contour. The remodeling algorithm was embedded 
in the model to achieve more physiologically reasonable platelet morphology. The 
simulated platelet deposition results were compared to two different modes of 
microfluidic experiments (the constant flow and pressure relief mode) [18].  In the 
constant flow mode, blood was perfused at constant flow rate through a microfluidic 
device where growing platelet deposits experience increasingly high shear as the clot 
grows across the channel. In the pressure relief mode, flow was diverted from the 
occluding channel to an open non-clotting channel so that clots were able to grow 
completely across the channel until flow stopped.  The multiscale model accurately 
simulated the platelet morphology and clot growth rates observed in the two different 
modes and provided quantitative predictions on platelet deposition dynamics consistent 
with experiments with healthy human blood treated with the Factor XIIa inhibitor, corn 
trypsin inhibitor (CTI). 
To our knowledge, this is the first model to quantitatively predict dynamic platelet 
deposition in the presence of wall-generated thrombin and inhibitors of ADP or 
thromboxane, as validated by comparison with actual data obtained with flowing human 
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blood.  Such predictions are novel and relevant given the clinical use of direct thrombin 
inhibitors and antiplatelet agents targeting ADP and thromboxane autocrinic signaling.  
While other models have predicted dynamic platelet deposition in the presence of 
thrombin generation [48], to our knowledge, this is also the first model to include 
inhibitors of ADP and thromboxane, agonists of the IP receptor, and be directly 
compared with experimental data. To our knowledge, this is also the first study to 
quantitatively predict platelet-mediated channel occlusion and to compare predicted 
occlusion times to actual measurements conducted under constant pressure drop 
conditions.    
 
3.2 Experimental methods 
3.2.1 Introduction of platelet activation and calcium measurement 
This section is adapted from [26] which contained more detailed description of 
the calcium measurement and neural network construction. 
Platelet activation during heart attack and stroke occurs through combined 
signaling pathways involving various receptors responding to collagen, thrombin, ADP, 
and thromboxane. Endothelial production of prostacyclin is highly protective against 
thrombotic platelet activation as revealed by the known cardiovascular risks of COX-2 
inhibitors. Similarly, endothelial production of NO has many cardiovascular effects via 
vasodilation and platelet inhibition. The clinical importance of these pathways is seen in 
the number of drugs in clinical trials or approved that target GPVI signaling, 
thromboxane, ADP, or thrombin. Clopidogrel antagonizes ADP activation of platelet 
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P2Y12 receptors and is widely prescribed. Numerous anticoagulants are approved to 
target the generation or activity of thrombin.  
Platelet activation occurs through multiple signaling pathways in which agonists 
bind specific receptors on the platelet to trigger signaling in a dose-dependent manner. 
During a clotting episode, platelets respond to exposed surface collagen, released ADP, 
synthesized thromboxane, and the serine protease thrombin, all while being 
simultaneously modulated by endothelial derived nitric oxide and prostacyclin. These 
receptor-mediated signaling pathways are not independent and significant crosstalk can 
occur (Figure 3-3). 
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Figure 3-3: Platelet calcium pathway involving six agonists (ADP, U46619, convulxin, thrombin, 
iloprost, GSNO) 
 
 
3.2.2 Pairwise agonist scanning and neural network training 
The pairwise agonist scanning and neural network training were in collaboration 
with Mei Yan Lee. Details of pairwise agonist scanning methods were shown in [26]. 
Platelet rich plasma (PRP) was then obtained by subjecting the whole blood sample to 
centrifugation at 120g for 12 minutes. Then, 2 ml of PRP was incubated with a vial 
(single microplate size) of Fluo-4 NW dye mixture (Invitrogen) reconstituted with 7.8 ml 
of HEPES buffer and 200 μL of 77 mg/ml reconstituted probenecid (Invitrogen) for 30 
minutes. All single and pairwise combinations of six agonists (ADP, convulxin, thrombin, 
U46619, iloprost and GSNO) at low, medium and high concentrations (0.1, 1, and 10x 
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EC50), as well as a buffer condition (154 conditions total x 2 replicates) were dispensed 
into a 384-well plate (called the ‘agonist plate’) using a high throughput liquid handler 
(PerkinElmer Janus). The PAS agonists were: ADP (P2Y1/P2Y12 activator, EC50 = 1 
μM), convulxin (GPVI activator, EC50 = 2 nM), thrombin (PAR1/PAR4 activator, EC50 = 
20 nM), U46619 (TP activator, EC50 = 1 μM), iloprost (IP activator, EC50 = 0.5 μM) and 
GSNO (NO donor, EC50 = 7 μM). ADP and GSNO were obtained from Sigma-Aldrich, 
convulxin from Pentapharm, thrombin from Haematologic Technologies Inc., U46619 
and iloprost from Tocris Bioscience. After incubation with dye, the PRP was dispensed 
into a 384-well plate (called the ‘read plate’). Both the agonist and read plate were loaded 
into a Molecular Devices FlexStation 3, a fluorescence reader with auto-pipetting 
capabilities. Agonists were dispensed to a column of wells containing the PRP, where 
well fluorescence  F t  was read and normalized by the pre-dispense baseline. 
Specifically, 20μL of agonist was added to 30μL of PRP in each well, giving a final 
volume of 50μL. In each well, the final concentration of PRP after agonist addition was 
12% PRP by vol., and the volume of calcium dye was 15μL (30% dye by vol.). Readings 
were taken in intervals of 2.5 seconds. The fluorescence was read for 20 seconds before 
dispense, and readings were taken for 210 seconds after each dispense (EX/EM, 485 
nm/525 nm). The entire plate was read, columnwise, in under 90 minutes. PAS was 
conducted on PRP from ten donors (50% male), each in replicate on two different days 
(20 PAS experiments total). In separate tests using indomethacin (Sigma-Aldrich) to 
block COX1 and apyrase (Sigma-Aldrich) to degrade released ADP, there was no 
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evidence for autocrine signaling in the dilute PRP conditions of the experiment, as 
previously found with EDTA-treated PRP [25] . 
3.2.2 Neural network training 
To train the NN, the loss function was chosen to be the pairwise synergy score 
( ijS ) which was defined to be the difference between the integrated calcium for the 
combined response to ij-agonists and the sum of the integrated calcium for both the 
individual agonist responses used independently, normalized by scaling to the maximum 
absolute synergy score observed in the experiment. The synergy scores take values from -
1 to 1 indicating from completely antagonistic to fully synergistic). In general, the n-
agonist synergy scores ( nS ) are defined by 
1...
1
1...
1
max
n
n i
i
n n
n i
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






     (3-1)  
where the variable Ai represents the integrated calcium for the response to agonist i used 
independently, and A1. . .n is the area under the curve for the response to agonists 1 
through n used simultaneously (n = 6 maximum for the six agonists deployed). The 
training result was shown in good agreement with experimental measure (Figure 3-4). 
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Figure 3-4 Neural network fit of PAS experiments. 
(A) PAS experiment input conditions: all single and pairwise combinations of six agonists at low, 
medium and high concentrations. (B) Measured average calcium time courses of ten donors in the 
PAS experiments. (C) The neural network trained on the PAS experiments of ten donors was able 
to fit the measured average pairwise calcium traces of those ten donors with a correlation 
coefficient of R = 0.975. (D) The experimental and NN-predicted 135 pairwise synergy scores for 
the PAS experiment. (E) The neural networks were able to fit the measured average pairwise 
synergy scores of those ten donors with a correlation coefficient of R = 0.937. (F) The 
experimental and NN-predicted synergy scores arranged by dose and agonist pairs. 
3.2.3 Blood collection and preparation 
Blood was collected via venipuncture into a syringe containing 40 μg/mL of a 
FXIIa inhibitor corn trypsin inhibitor (CTI, Haematologic Technologies, Essex Junction, 
VT)  from healthy donors who self-reported as free of alcohol use and had refrained from 
oral medication for at least 72 hours prior to donation.  All donors provided informed 
consent under approval of the University of Pennsylvania Institutional Review Board. 
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Platelets were labeled with anti-human CD61 antibody. Fluorescent fibrinogen was added 
(1 mg/mL stock solution, 1:80 v/v % in whole blood) for measuring fibrin generation. All 
experiments were initiated within 5 minutes after phlebotomy. 
3.2.4 Preparation and characterization of collagen/TF surface 
Glass slides were treated with Sigmacote (Sigma, St. Louis, MO) to impede protein 
adsorption and clotting on glass surface. A volume of 5 μL of collagen was perfused 
through the patterning channel (250 μm wide and 60 μm high) of a microfluidic device to 
create a single stripe of fibrillar collagen, as previously described by Neeves, et al. [17] 
Lipidated TF was then sorbed to the collagen surface by introduction of 5 μL of Dade 
Innovin PT reagent (20 nM stock concentration) [59] diluted 300-, and 5- fold with N-2-
hydroxyethylpiperazine-N9-2-ethanesulfonic acid buffered saline to obtain low, and high 
TF surface concentrations of  0.1 and 10 molecules per μm
2
 , respectively, as estimated 
by imaging of sorbed annexin V-fluorescein isothiocyanate–stained vesicles.[58] In all 
experiments, the Dade Innovin PT reagent was incubated with the collagen for 30 
minutes without flow and the  surface was then rinsed and blocked with  0.1% bovine 
serum albumin buffer. 
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3.2.5 Microfluidic clotting assay on collagen surfaces with or without TF 
 
Figure 3-5: The 8-channel microfluidic device and epifluorescence microscopy (A,B). 
 
An 8-channel polydimethylsiloxane flow device (Figure 3-5), described by Maloney et al. 
[19], was vacuum-mounted perpendicularly to collagen/TF surfaces forming 8 parallel-
spaced prothrombotic patches 250 μm wide by 250 μm long. Blood was then perfused 
across the 8 channels to be withdrawn through a single outlet. Initial wall shear rate was 
controlled by a syringe pump (Harvard PHD 2000; Harvard Apparatus, Holliston, MA) 
connected to the outlet on the flow device to maintain a venous shear rate of 200 s
-1
 
(corresponding to a volumetric flow rate of 2 μL/min/channel). Thrombi were formed 
either under constant flow rate (constant Q; CTI-treated blood in all 8 channels) or under 
constant pressure drop (constant DP) conditions as described by Colace et al. [20] To 
achieve constant pressure drop (pressure relief mode), EDTA-treated blood was delivered 
into alternating channels to abolish thrombus formation, thus allowing CTI-treated blood 
to clot in assay channels and divert flow into the matched EDTA channels. Platelet and 
fibrin activity were monitored simultaneously by epifluorescence microscopy (IX81; 
Olympus America Inc., Center Valley, PA). Images were captured with a charged 
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coupled device camera (Hamamatsu, Bridgewater, NJ) and were analyzed with ImageJ 
software (National Institutes of Health). To avoid side-wall effects, fluorescence values 
were taken only from the central 75% of the channel. 
3.2.6 Confocal imaging of clot morphology and flow rate 
Real-time clot height was determined by platelet fluorescent intensity, which was linearly 
proportional to the fluorescent intensity of a fully occluded thrombus. Experiments were 
terminated when flow was in complete cessation (full channel occlusion) in assay 
channels for the pressure relief condition and final clot height was assumed to be the 
same as the height of the channel (60 μm). Profiles of clot morphology were generated 
using a custom MATLAB script, in which the average of 40 vertical line-scans (in the 
direction of flow) was calculated. The height was also assumed to be proportional to the 
fluorescence level and was calibrated by the maximum intensity for a fully occluded 
thrombus. Supplemented fluorescent fibrinogen provides a fluorescent background in 
assay channels while EDTA channels remain dark all the time. Flow rate in assay channel 
was determined by measuring the width of the fluorescent portion in the middle flow 
plane at the merged outlet of every two paired channels at each time point and calculating 
the corresponded volumetric flow rate within the fluorescent portion of the channel using 
a custom MATLAB script with assumptions that a parabolic flow profile was fully 
developed. 
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3.2 Model specification 
3.2.1 Schematics of the multiscale model 
 
Figure 3-6: The simulation domain in comparison with the microfluidic device 
 
A 2D rectangular simulation domain (500 μm long x 60 μm high) was used for all 
simulations (Figure 3-6B).  At a location between 100 and 350 μm downstream of the 
simulation domain entrance, a 250-μm collagen patch was defined as a boundary 
condition.  The 2D computational domain represented a centerline cross-section of an 
actual 3D microfluidic channel (250 μm wide x 60 μm high) used to perform the ex vivo 
whole blood perfusion experiments (Figure 3-6A).  
The overall computational framework is composed of four interacting modules.  
At the center of the framework, a Lattice Kinetic Monte Carlo (LKMC) simulator is used 
to evolve platelet positions in time.  Platelets are assumed to be rigid, circular objects.  
The LKMC simulation is informed by the three other computational modules.  First, the 
flow field, which convects the platelets down the microchannel, is computed with the 
lattice Boltzmann (LB) method. The LB simulation assumes a quasi-steady flow profile 
that depends on the instantaneous thrombus boundary location and is resolved at a 
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resolution approaching the single platelet scale.  Next, the concentration profiles of the 
soluble platelet agonists (ADP, TXA2, and thrombin) are described by a system of 
convection-diffusion-reaction equations that are solved using finite element method 
(FEM). Finally, the activation state of each platelet, as defined using a metric based on 
intracellular calcium [Ca
2+
(t)]i is calculated in time using the neural network (NN) model 
for the unique multicomponent agonist exposure experienced by each platelet.  The 
connectivity between these various computational modules is shown in (Figure 3-7).  
Each of the 4 computational modules is described in detail in the following sections. The 
computational grids for different modules are shown in (Figure 3-8). 
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Figure 3-7: Multiscale model coupling 
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Figure 3-8: Simulation domains and meshes for the different modules.  
In LKMC, each platelet (red circle) is resolved with multiple square elements (lattice spacing of 
0.5 μm). In LB, the uniform grid had the same lattice spacing as LKMC, but was offset by 0.25 
μm in each direction such that the LB nodes surround the LKMC pixels.  In FEM, a refined 
triangular mesh was generated around the clotting region such that each platelet occupies 
approximately 30 triangular elements. LKMC feeds platelet information such as position and 
activation states into LB and FEM. FEM computes concentration field for soluble species 
interpolated back onto the LKMC grids. LB computes the velocity field used by both FEM and 
LKMC. 
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3.2.2 Kinetic Monte Carlo  
The lattice Kinetic Monte Carlo (LKMC) module was used to simulate the 
dynamics of platelet transport and deposition under blood flow. The LKMC simulation 
was executed on a square grid with lattice spacing, 0.5h m , while platelets were 
assumed to be circular with radius (1.5 μm).  Platelet transport events were defined as (1) 
diffusion with rate 
2
platelet
D
LKMC
D
h
  ,  where plateletD  was the effective diffusivity accounting 
for both Brownian motion and the red blood cell (RBC) dispersion effect [41], and (2) 
advection with rate iC
LKMC
v
h
  , where iv  was the fluid velocity component along the 
lattice direction ie . The total rate of motion for each platelet was the sum of the 
convective and diffusive rates. This approach was validated in our earlier work [39].   
Red blood cells (RBC) also play a significant role in platelet motion. Besides augmenting 
the apparent diffusivity of platelets, flowing RBCs also generate an excess of platelet 
concentration in the plasma layer near the boundary, which was modelled as an additional 
radial drift velocity superimposed on the actual velocity that resulted in a 3-fold wall 
excess of platelets [40]  (Figure 3-9). The drift velocity in the two dimensional channel is 
positive toward the wall within 3 μms, thereby causing extra momentum of hitting the 
thrombus.  
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Figure 3-9: Inlet platelet concentration distribution and drift velocity.  
The inlet platelet concentration distribution was biased near-wall due to the red blood cell effect. 
The platelet near wall has excess concentration (left) Platelet drift velocity due to RBC motions 
from Yeh, Calvez, and Eckstein [40]. A positive velocity points away from the wall, while the 
negative velocity within the center of the channel pushes platelets towards the wall (right). 
 
In addition to the convection-dispersion-drift events for each platelet, we also considered 
the activation-dependent rates of attachment and detachment between 2 platelets, or 
between a platelet and the collagen boundary. Both cumulative and recent-history 
activation levels were considered for each platelet. The cumulative internal activation 
state,  , of the i-th platelet at time t was defined as the accumulated integral calcium 
concentration above the basal level: 
      
0
t
i i baseline
t Ca Ca d    ,      (3-2)               
where   100
baseline
Ca nM  [60]. The recent-history activation level was defined as the 
accumulated calcium level between the current time t and previous time t t   
( 30sect   ):  
    ,
t
t i i baselinet t
Ca Ca d 

   .      (3-3) 
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The recent-history activation metric allows platelet integrins to return to a resting state 
(nonadhesive) if calcium has returned to baseline for 30 sec.  One of the most widely 
used functional forms, the Hill functions were introduced to normalize, between   min  = 
0.001 and 1, the cumulative and 30-sec recent history activation states:  
      min min ,
50
1 , ,
n
i
i i i t in n
i
F

     
 
   

,                 (3-4)                                          
where   represents the base level of activation, n represents the sharpness of the Hill 
function, and   was the critical level for 50% activation.  An overall rate of attachment of 
the i-th platelet to the collagen surface was defined by:  
    ,
collagen collagen
att att t ik F F   .      (3-5)  
The attachment rate between the i-th and j-th platelet, via fibrinogen depending on both 
the cumulative and transient calcium level of two particles was modelled as: 
       , ,fibrinogen fibrinogenatt att i j t i t jk F F F F       .   (3-6)  
The detachment rate between platelet and the reactive surface was modelled using the 
Bell exponential [61] to describe the shear-dependent breakage of receptor-ligand bonds,  
    
11
det det , exp
collagen collagen i
i t i
c
k F F

 



 
   
 
,    (3-7) 
where i   was the local shear rate around the i-th platelet and c  was the characteristic 
shear rate required to initiate bond breakage. The detachment rate between the i-th and j-
th platelet was given similarly by  
       
1 1
det det , , exp
2
i jfibrinogen fibrinogen
i j t i t j
c
k F F F F
 
   

 
 
 
   
 
 . (3-8) 
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In the current model, platelets could only dissociate as singlets from the thrombus and 
fracture of large chunks of platelets was not considered due to the complexity of stress 
propagation within the random aggregated clot. Platelets displayed no bulk aggregation 
as they entered the concentration boundary layer due to short exposure times and rarity of 
collisions in the bulk flow. Therefore, aggregation for free-flowing platelets was not 
considered. 
At each time step, a specific event k with rate k  was chosen from the rate catalog 
with probability /k total  . A specific time step  ln / totalu      was also chosen by 
drawing a random number u from the unit interval (0, 1] .  To update the system clock, 
the next reaction method was used where the presumptive wait times were calculated for 
each time step, which include the following steps: 
1. Initialize particle occupancy based on the radial platelet distribution and density. 
2. Calculate all the rate events: motion events, binding/unbinding of fibrinogen, 
collagen if applicable. 
3. Generate random wait times based on the rate information. 
4. An event with the shortest wait time is executed. Reallocate the particle or update 
the binding/unbinding kinetics for all particles under influence. 
5. Update the system clock and go back to step 3 until desired simulation ends. 
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3.2.3 Lattice Boltzmann  
The lattice Boltzmann (LB) method was used to solve the flow field around the 
platelets satisfying the incompressible Navier Stokes equation with continuity condition. 
A D2Q9 (two dimensions with nine nodes) scheme with Zou-He Boundary conditions 
was applied [53]. The top and bottom walls were treated as no-slip surfaces. Platelets 
were simulated as pixelated objects on the LKMC lattice (Figure 3-8). Free flowing 
platelets and their interactions with each other were ignored in the LB model of 
Newtonian blood flow.  However, the hydrodynamic effect of a clot-bound platelet on the 
fluid was explicitly handled in the LB model as a no-slip surface. The current LB 
algorithm used the BGK propagator and had two main steps: collision and streaming. 
During a streaming step, fluid at each node stream to its eight nearest neighbor and itself. 
During a collision step, fluid is relaxed to an equilibrium configuration. The time step for 
the streaming and collision was set as 
71 10LBt s
   . Quasi-steady flow was assumed 
and the flow field was only updated when there was change in the thrombus contour. 
During each update, LB received the current configuration of bound platelets from 
LKMC and LB was simulated until the next update system time. The time scale for 
velocity field relaxation was generally far less than 10
-3 
s, so the velocity field update was 
finished long before the next system update time ( 0.001systemt s   ). Therefore, the quasi-
steady approximation was valid and significantly saved computational resources 
extending the time domain of the simulation to more than 1000 seconds.  
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Figure 3-10: Initial shear distribution for the pressure relief experimental settings.  
Initial wall shear was set to 200 s
-1
. Flow was diverted to the open channel as the thrombotic 
active channel was blocked by depositing platelets. 
 
Two different experimental settings, constant flow rate mode and pressure relief 
mode, were simulated.  In the constant flow rate mode, blood was perfused over the 
microfluidic channel at a constant flow rate regardless of the size of the developing 
platelet deposit on the wall.  In the pressure relief mode (Figure 3-10), two identical 
channels in parallel with a single outlet were perfused.  Only one channel experienced 
obstruction caused by deposited platelets, while the other channel had no wall deposit 
(EDTA-treated blood in the real experiment).  With increasing flow resistance caused by 
platelet accumulation, flow was diverted to the free channel which eventually led to zero 
flow in the fully obstructed channel.   In the constant flow rate mode, a parabolic flow 
profile with initial wall shear of 200 s
-1
 was maintained at the inlet. In the pressure relief 
mode, a similar parabolic flow allowing the same wall shear for both of the two channels 
was maintained at the outlet.  The major difference between the two designs lies in the 
shear distribution for a well-developed clot. The constant flow as the name suggests, 
maintains a constant volumetric flow rate despite the change in resistance caused by a 
growing thrombus. Therefore, the flow acceleration became significant for a nearly 
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occluded thrombus. The shear rate along the thrombus contour reached beyond 6000 s
-1
, 
involving additional binding mechanisms of von Willebrand factor (vWF) which was not 
considered in the current model. The pressure relief mode on the other hand helped to 
maintain a reasonable low shear condition (~400 s
-1
) therefore creating a more stable 
thrombus structure. The pressure relief experiments and simulations both manifested the 
possibility of full occlusion.  
3.2.3 Finite Element method 
The concentration fields of the agonists,  , ,jC x y t for j = ADP, TXA2, and thrombin 
were obtained by solving a system of convection-diffusion-reaction equations using the 
finite element method (FEM): 
                  2 ,
j
j j j j
C
C D C R
t

    

v          (3-9)                                                                                 
where jD  was the Brownian diffusion coefficient of ADP, TXA2 and thrombin, and v  
was the fluid velocity provided by the LB module. The release of ADP and TXA2 by the 
i-th platelet was triggered by its internal activation state,       
0
t
i i baseline
t Ca Ca d    
exceeding a critical level of 9 seccrit m  .  Once sufficiently activated, the platelet 
released ADP and TXA2 with rates governed by an exponential decay function, 
  expj releasej release
j j
M t t
R t for t t
 
 
    
 
,   (3-10) 
            
where jM  was the total moles of species j for a platelet and j  was a time constant. 
Published experiments had determined that each platelet can release 1 × 10
-8
 nmol of 
ADP with a time constant of 5 sec [62,63] and 4 x 10
-10
 nmol of TXA2 with a time 
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constant of 100 sec [64]. The element at the center of the activated platelet was treated as 
the source element for the PDE calculation (FEM). The velocity in an element was 
directly interpolated from the LB velocity field. The release rate within an element was 
taken as the area-weighted release rate of all platelets within the element. Agonists were 
assumed to undergo transport by diffusion within the platelet mass. The location of 
platelets was used to pinpoint the location of the source term yet they also implicitly 
determine the LB flow field. The soluble species can be transported through platelets as if 
they were stagnant fluid. The weak form of the original PDE was obtained by weighting 
each term with the interpolation functions and integrating over each element. The time 
derivative was estimated using the Implicit Euler method. 
3.2.4 Cell activation-driven adaptive meshing 
An important feature of platelet deposition is that the clotting region, especially at 
early times, occupies only a small portion of the computational domain. Consequently, 
using a uniform mesh throughout the entire domain incurs a large computational cost 
where many mesh nodes must be applied to achieve a reasonable resolution around each 
platelet.  An adaptive meshing scheme was designed to allow the mesh density to be 
refined in the clotting region of an evolving rough clot surface. The mesh generator 
DistMesh [65] with a Gaussian size function was used to produce an unstructured 
triangular mesh (Figure 3-11).   
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Figure 3-11: Platelet activation-driven adaptive triangular meshing 
The 2D Gaussian influence function and the resultant meshes for an example case of two adjacent 
and activated platelets (A). The triangular mesh is shown for a typical thrombus configuration 
and the resultant concentration fields for ADP and TXA2 as well as each platelet’s activation state 
of integrated intracellular calcium (B).  
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DistMesh is based on a simple mechanical analogy between a triangular mesh and 
a 2-D truss structure, or equivalently a structure of springs. Any set of points in the x, y-
plane can be triangulated by the Delaunay algorithm. In the physical model, the edges of 
the triangles (the connections between pairs of points) correspond to bars, and the points 
correspond to joints of the truss. The edges of the triangles experience external forces 
which are linearly elastic forces defined as proportional to the difference between the 
equilibrium bar length and the actual length. The equilibrium lengths of the triangles are 
defined by a size function  ,h x y . For any point located on the 2-D domain, the size 
function returns the equilibrium length which governs the forces exerted on the bar 
therefore the movement of the overall truss structure. One simple example of the size 
function is  , 1h x y   . This means all the bars at equilibrium will have nearly equal 
lengths, thus the domain will be mapped by equilateral triangles at the end. 
In order to find the equilibrium of the truss structure, the scaled forces vectors 
 F p of all the meshpoints p  are computed and the system is evolved by the ODE 
 
d
F
dt

p
p  with initial condition 0p  being the initial location vector of all points p . The 
points are evolved by using the forward Euler scheme,  1n n ntF  p p p  until 
equilibrium is reached   0
d
F
dt
 
p
p . Those points that are pushed outside the domain 
will be projected back to the boundary. For each bar of the triangles we compute the 
equilibrium bar length by the output of the size of function at the center of the bar and 
therefore forces can be computed using a linear elastic force scheme 
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   0 0 0
0
, ;
0 ;
f l l k l l if l l
f l l
  
 
      (3-11) 
The initial condition is usually the uniform distribution of equilateral triangles 
with edge length user-defined edge length h0 with size function  , 1h x y  . When 
geometric adaptivity is desired (i.e.,  ,h x y  is non-uniform), the convergence is faster if 
the initial distribution is weighted by probabilities proportional to  
2
1/ ,h x y  (which is 
the density). The rejection method starts with a uniform initial mesh inside the domain, 
and discards points using this probability. The triangulation of points is performed by the 
robust Delaunay triangulation algorithm which maximizes the minimal angle of the 
triangles and thus keeps good mesh qualities. For each step with an appreciable change of 
the mesh point locations, a new Delaunay triangulation is performed. The stopping 
criterion for the DistMesh algorithm is when the infinity norm of the force vector is less 
than certain maximum tolerance. The flow chart of the algorithm is shown in Figure 3-12. 
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Figure 3-12: Flowchart for the DistMesh algorithm 
 
The size function is defined as the superimposition of individual Gaussian 
influence functions for all activated platelets. For the i-th platelet that reached the critical 
activation state, we computed a 2D Gaussian, ig , around the platelet center:  
   
2 2
2
exp
2
i i
i
x x y y
g

   
  
 
 
,                (3-12)              
                
where ix , iy  are coordinates of the center of the i-th platelet, σ was a parameter that 
describes the spread off the Gaussian in both directions. The overall influence function 
 ,G x y  was defined as the sum of all Gaussians of single platelets, i.e., 
 
   
2 2
2
, exp
2
i i
all activated platelets
x x y y
G x y

   
  
 
 
 .  (3-13) 
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The size function  ,h x y  defined the equilibrium length of the triangular element 
by the Gaussian influence level as follows: 
   
   
min
min max
, ,
min , , otherwise
cutoff
cutoff
h x y h if G x y G
h G x y G h
 
  
   (3-14)  
where  ,h x y  was the minimum equilibrium length of triangles,  maxh  was the maximum 
equilibrium length of triangles, α was the slope of change in the transition region and 
cutoffG  was the  cutoff level for the influence.  
The following (Figure 3-13, 14, 15, 16) showed the evolution of the mesh configuration 
depending on the growing platelet mass.  
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Figure 3-13: Mesh configuration at 20 seconds 
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Figure 3-14: Mesh configuration at 100 seconds 
 
 
 
 
 
 
 
 
 
 
63 
 
 
 
 
 
Figure 3-15: Mesh configuration at 200 seconds 
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Figure 3-16: Mesh configuration at 300 seconds 
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3.2.5 Neural Network 
Pairwise Agonist Scanning (PAS) was used to obtain calcium traces for apixaban-
treated, diluted, and calcium dye-loaded platelet rich plasma (PRP) stimulated with all 
single and pairwise combinations of 6 different agonists used at low, medium, and high 
concentrations (0.1, 1, and 10 x EC50) [25]. In this approach, the 6 agonists used were: 
ADP, U46619 (thromboxane mimetic), convulxin (collagen mimetic), thrombin, GSNO 
(NO donor), and iloprost (prostacyclin analog). Neural network training was then carried 
out using the Neural Network Toolbox in the MATLAB software package to predict 
platelet calcium level for any agonist dose and combination. Output concentrations were 
mapped between 0 (resting calcium levels) and 1 (maximal response). The structure of 
the NARX (Nonlinear AutoRegressive network with eXogenous inputs) model utilized 2-
layer processing (8 nodes in the first layer and 4 nodes in the second layer) and a tapped 
delay line with 128 sec of feedback to each layer (Figure 3-2). The hyperbolic tangent 
transfer function was used in all nodes and a linear transfer function was used in the 
output layer. Initial states of the feedback were set to 0 corresponding to the resting 
platelet. The NN predicted the calcium level for the next time step based on the feedback 
vector (1, 2, 4, 8, 16, 32, 64 and 128 sec prior to the current instant) and the current 
concentration input from the 6 agonists.   
To be more specific, the NN predicts the time-dependent intercellular calcium 
concentration, [Ca
2+
(t)] from time histories of local agonist concentrations, 
            , , , 46619 , ,c ADP CVX IIa TXA U Illoprost GSNO    . The platelet calcium 
measurements were performed with convulxin (CVX) instead of collagen, so the 
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effective potency of the collagen patch is determined by the CVX concentration, which 
was an input into the simulation. The agonist concentrations were all mapped to the 
interval  1,1  from a log scale with -1, -1/3, 1/3, 1 correspond to 0.01EC50, 0.1EC50, 
1EC50, 10EC50 respectively. For agonist study, one of the procoagulant agonists (ADP, 
TXA2, IIa) was inhibited and set to -1. The local agonist concentration for each platelet 
was determined by interpolating from the corresponding element of the concentration 
field.  
The mapped inputs  
6 1
c

 were fed into each node of the first layer which was multiplied 
by the first-layer weight matrix  
8 6
IW

. The calcium concentration feedback vector 
 8 1
z

 
at the time instant  1, 2, 4, 8, 16, 32, 64, 128t t t t t t t t        s, was added on the 
first processing layer after multiplication with the weight matrix  
8 8
1A

. The sum of the 
weighted results was added with a constant bias  
8 1
1b

at each node and was transformed 
with the hyperbolic tangent function. The result after the first layer  
8 1
1l

 was fed into 
each node of the second layer which was multiplied by the second-layer weight matrix 
 4 8
1LW

. The feedback vector was again processed with second-layer weight matrix 
 4 8
2A

. The sum of the weighted results from the second layer was again added with a 
constant second-layer bias  
4 1
2b

at each node and was transformed with the hyperbolic 
tangent function a well. 
The output from the first layer was given by 
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            
 8 1
8 1 8 6 6 1 8 8 8 1 8 1
1 1 1l f IW c A z b

     
   (3-15) 
where    tanhf x x  
The output from the second layer was given by 
            
 4 1
4 1 4 8 8 1 4 8 8 1 4 1
2 1 1 2 2l f LW l A z b

     
      (3-16)  
The output from the NN was 
 
       1 1 1 4 4 1 1 1
2 2 3y t LW l b
   
        (3-17) 
A 100 NN-ensemble for PAS of 10 healthy donors and 10 trained NNs per donor 
predicted averaged calcium concentration output for human platelets exposed to any 
combinations of the 6 agonists.  This approach captured the measured information from 
6160 calcium traces containing 511,280 calcium data points. The overall output of the 
NN was an average of the 100 individual NNs. See [26] for detailed information 
validating PAS-NN prediction of [Ca
2+
(t)]i beyond the pairwise training set for trinary 
stimulations, 4-6 agonist stimulations, and sequential agonist stimulations.  
3.2.6 Thrombin release modeled as boundary flux 
Motivated by the work of Kuharsky and Fogelson [28] and numerous 
observations of a thin thrombin/fibrin core that is immediately adjacent to wall-derived 
TF [20], thrombin was introduced into the computational domain as a time-dependent 
wall boundary flux condition. This boundary flux assumption is consistent with a fixed 
amount of Factor X (FX) being activated to FXa near the wall due to extreme transport 
limits on FX diffusion through a dense and activated platelet aggregate since FX binds to 
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activated platelets [47,66-68].  Instead of resolving the full detail of the coagulation 
cascade, which involves ~50 PDEs and ~100 reactions where many of reaction kinetics 
has yet to be verified experimentally within dense platelet deposits formed under flow, 
thrombin was simulated as an imposed boundary flux at the wall with an initiation phase 
followed by a decay phase whose shape and peak value was motivated from both 
Calibrated Automated Thrombography (CAT) and a previously validated ODE model 
[29].  
Since measurements are not available for intrathrombus thrombin generation per 
molecule of TF on a surface, a 400-sec thrombin flux profile (J, nmole/μm
2
-sec) was 
studied parametrically in 3 cases. Case I: strong thrombin flux for high [16]wall = 10 
molecule-TF/μm
2
; Case II: weak thrombin flux for low [16]wall = 0.1 molecule-TF/μm
2
; 
and Case III: zero thrombin flux for TF-free wall condition. A two-piece cubic spline (8 
degrees-of-freedom) for the thrombin flux was defined for the initiation and decay phases 
with the following imposed constraints: zero flux at the initial and final time of 400 sec, 
continuity, slope and curvature matching at the joint, and zero slope at the final time.  
These constraints reduce the degrees-of-freedom to only 2 parameters: time to peak flux, 
Tmax, and peak flux, Jmax.  The 3 cases of thrombin flux are shown in Figure 3-17. Tmax 
was set to 160 sec, a time typical for onset of fibrin generation at high concentration of 
[16]wall [20,69]. The peak flux value imposed underneath the growing platelet deposit 
(where convection is minimal) was set to Jmax = 8 x 10
-12
 nmole/μm
2
-sec, which is 10 to 
100-fold less than the imposed flux needed to polymerize fibrin from flowing fibrinogen 
over a membrane  [70]. Case II deployed a five-fold reduction in Jmax to simulate the 
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situation of a typical low TF (~0.1 /μm
2
) stimulation. By testing against measured clot 
growth rates, Cases I and II represent predictions of the multiscale model that potentially 
can be compared to future measurements of thrombin generation by a growing thrombus. 
While the thrombin flux condition was inspired by the CAT assay (closed system) 
corresponding to a partially restricted inner clot “compartment”, clot formation over 
collagen/TF under flow is an open system.  It remains to be determined if influx of 
prothrombin can lead to a plateau in thrombin production.  Future measurements of 
dynamic thrombin flux from clots formed under flow will help refine the wall flux term.   
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Figure 3-17 Comparison of different thrombin flux signals for constant flow rate simulations at 
initial inlet wall shear rate = 200 s
-1
.  
Different thrombin flux conditions were imposed on the wall. Case I represents normal 
physiological condition (Tmax=160 seconds, Jmax=8E-12 nmol/ μm
2
) under high TF stimulation. 
Case II has a five-fold reduction in Jmax. Case III shows a base case with zero thrombin. (A) 
Thrombin boundary layer for three cases at 200 seconds. (B) Averaged thrombin for the thrombus 
as a function of time for three cases. (C) Snapshots of fully-developed thrombus configuration at 
400 seconds for three different cases. (D) Comparison of platelet accumulation dynamics for 
three different cases. (E) Averaged shear rate at the outmost layer of platelets for three different 
cases. (F) 
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3.2.7 Clot remodeling scheme 
Platelets can transiently roll (translocate) on VWF prior to firm arrest mediated by 
integrin activation. However, resolving molecular-level events of detailed adhesion and 
restructuring mechanics incurs too much computational cost given the spatial and 
temporal domain of thrombosis (1000’s of cells over many minutes and millimeters). A 
remodeling algorithm was thus designed to mimic the remodeling behavior without 
providing full descriptions of the inherent biology. Upon binding, each platelet was able 
to roll a certain distance along the trajectory of the thrombus contour in the flow direction. 
A typical rolling distance of 10 μm is observed by tracking single platelet movement 
under microscopes. Under the square lattice settings, each platelet occupied a collection 
of pixelated squares in the domain. As shown in Figure 3-18, whenever a quiescent 
platelet (in black) attempted to bind to the target platelet (in gray), a search was 
performed along all the potential binding sites (trajectory shown in red) in the direction of 
the local flow. Upon binding, the algorithm allowed the platelet to search along the 
contour of the thrombus for a distance of 10 μm (observed under microscopes) based on 
local flow and morphology. A list of all the potential binding sites along the search 
trajectory and their corresponding potential binding rates were evaluated. Sites with 
higher binding rates would be more likely to be chosen. The algorithm picks the final 
deposition site based the potential binding rates which are the sums of all the platelets 
acting on that site. For instance, a site with 3 neighboring platelets (assuming all with the 
same activation levels, therefore same binding rates) will be 3 times more likely to be 
chosen than one with only one neighbor. Denser packing is an emergent outcome since 
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sites that can form close packing are more likely to be chosen as these sites tend to have 
more platelets acting on them, thus higher potential binding rates. 
This remodeling algorithm circumvented the biological complexity of detailed 
receptor adhesive dynamics calculations, but allowed the platelet to search for a favored 
site for binding, mimicking the rolling and translocation behavior observed both in vitro 
and in vivo.  
 
Figure 3-18: Remodeling algorithm for platelet deposition.  
Upon binding, the number of contacts the adhering platelet experiences (color coded at each cell 
center position along the trajectory) is calculated until forbidden overlap is achieved, whereby the 
most favorable binding site was chosen based on the cumulative potential binding rates. 
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3.2.8 Module integration 
Exchange of information between the 4 computational modules was performed at 
specified time intervals (Figure: 3-19): 35 10LKMCt s
   , 35 10LBt s
   , 
210FEMt s
   and 210NNt s
  . At the start of the simulation, the LKMC, LB, FEM, 
and NN modules were all initialized.  Each module was then stepped forward in time 
until the first coupling time was reached ( 35 10t s  ), and then information was 
exchanged between relevant modules. When the total time evolved by the LKMC module 
first exceeded LKMCt  , each of the 3 modules, LB, NN and FEM was updated to the 
current system time. During the first update time (~
35 10t s  ), the LB solver received 
the current configuration of the bound platelets from the LKMC simulation and was used 
to update the velocity field to the current system time. Then, all methods resumed 
stepping forward in time until the next coupling time (
210t s ) occurred. At the time of 
update, all models shared information: the LKMC was used to update position of platelets 
in FEM, LB; LB updated the velocity field in LKMC and FEM; FEM updated the 
concentration field; and NN predicted the activation state of each platelet based on 
updated agonist concentrations to be used in LKMC and FEM. This process was repeated 
until the end of the specified simulation time. The overall multi-element model used 25 
parameters (Table 1), the first 15 of which are either well-characterized physical or 
biological properties (ρblood, μblood, etc.) and the remaining 10 parameters (n, ξ50, …, and 
γc) were determined from our previous model [49] and experimental measurements. 
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Figure 3-19: Multiscale model time stepping 
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Table 1: Experimentally determined parameters for multiscale modeling of thrombosis 
  
 
 
 
 
 
 
Symbol Name Value [Ref.]/Comment 
ρblood Density of blood 1 g/cm
3 
[71] 
Nplatelet Platelet count 1.5 x 10
5 
platelet/μL 
[72] 
μblood Viscosity of blood 0.03 g/cm s [73] 
Rplatelet Radius of platelet 1.5 x 10
-4
 cm [74] 
Dplatelet Diffusion (dispersion) Coefficient 
of platelet 
1.25 x 10
-7
 
cm
2
/s 
[41] 
DATP Diffusion (dispersion) Coefficient 
of ADP 
2.37 x 10
-6
 
cm
2
/s 
[62] 
DTXA2 Diffusion (dispersion) Coefficient 
of TXA2 
2.14 x 10
-6
 
cm
2
/s 
[62] 
DFIIa Diffusion (dispersion) Coefficient 
of thrombin  
4.21 x 10
-7
 
cm
2
/s 
[20] 
MADP Total amount of ADP released 1 x 10
-8
 
nmoles/platelet 
[63] 
MTXA2 Total amount of TXA2 generated 
upon activation 
4 x 10
-10
 
nmoles/platelet 
[64] 
τADP Characteristic release time constant 
for ADP 
5 s [75] 
τTXA2 Characteristic release time constant 
for TXA2 
100 s [64] 
CCVX Effective concentration of collagen 
(in units of CVX) 
0.3 x EC50 Soluble vs 
surface ligand 
θ Relative potency of TXA2/U46619 15 Relative binding 
affinity for TP 
receptor 
α Resting level of integrin activation 0.001 ~ 1 active 
integrin per 1000 
on a resting 
platelet. 
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Table 2: Estimated parameters for multiscale modeling of thrombosis 
 
 
 
 
 
 
 
 
 
 
 
 
 
Estimated 
parameters 
   
n Sharpness of activation function 
for total calcium integral 
0.75 Expected range:  
0.5 < n < 2 
namp Sharpness of activation function 
for transient calcium integral 
3  
ξ50 Critical value for 50% activation 
and platelet release 
9 μM-s Strong calcium 
mobilization 
(e.g. 1 μM 
persisting for 10 
sec.) 
collagen
attk  Attachment rate constant for 
collagen binding 
1000 s
-1 
Includes 
vWF/GPIb. 
fbg
attk  Attachment rate constant for 
fibrinogen-mediated binding 
50 s
-1 
 
det
collagenk  Detachment rate constant for 
collagen binding 
1 x 10
-5
 s
-1
  
det
fbgk  Detachment rate constant for 
fibrinogen-mediated binding 
1 x 10
-4
 s
-1
  
γc Critical shear rate 200 s
-1 
 
Tmax Time to peak thrombin 160 s  
Jmax Maximum thrombin flux  8 x 10
-12
 
nmole/μm
2
-s 
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3.3 Results 
3.3.1 Cell activation-driven adaptive meshing     
The FEM mesh for calculation of agonist transport was generated by the 
remeshing algorithm described in Section 3.2.3. The adaptive remeshing algorithm 
allowed for automatic generation of mesh configurations for any specific platelet contour 
shape that resulted stochastically from LKMC. Starting from an initially coarse uniform 
mesh over the entire 500 μm x 60 μm simulation domain, the remeshing algorithm 
generated a highly resolved mesh in proximity to the growing thrombus contour, as 
required to resolve the boundary layers associated with the agonist concentrations. The 
equilibrium side length of the smallest triangles in the clotting region was set to 0.7 μm.  
For the earlier stages, the clotting region only occupied a small portion of the domain, 
and a mesh with no more than 8000 nodes was usually sufficient. For a fully developed 
thrombus, the program generated an unstructured triangular mesh with about 30,000 
nodes and 50,000 triangular elements (Figure 3-11B).  For the same domain of 500 μm 
by 60 μm, using a uniform square mesh with 1μm spacing in both directions would 
require as many as 30000 (500×60) nodes and 60000 elements. Each activated 3-μm 
diameter platelet occupied about 30 triangular elements (side length = 0.7 μm) compared 
to 9 elements for uniform meshing.  Therefore, a three-fold increase in mesh resolution 
was achieved at the site of each platelet’s release of ADP and TXA2 while applying 
coarsened meshes elsewhere therefore maintaining a similar problem size. Computational 
power was especially focused during the early stages of clotting when only a few 
platelets were immobilized to the surface, with these initial events driving subsequent 
78 
 
pattern formation. The refined regions occupied the concentration boundary layer 
extending up to ~10 μm from the platelets on the outermost layer, thus coinciding with 
the regions where the sharp gradient change in agonist concentrations emerged from the 
simulation.  A new mesh was generated only if the current mesh resolution for one or 
several activated platelets fails to reach the tolerance criteria. Over the course of one 
simulation, a total of 25 different meshes were used and mesh update was more frequent 
during the earlier development stage. The triangular elements were of high quality with 
appropriate aspect ratio (Figure 3-20) for stable and accurate finite element calculations. 
Overall, the adaptive remeshing scheme led to about 40% reduction in computational 
effort relative to the simulations with uniform meshes, with most of the savings occurring 
during the earlier stages of clotting.  
 
Figure 3-20: Histogram for mesh quality obtained by the adaptive meshing scheme. Most of the 
triangular elements had very high mesh quality (>0.9). 
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While adaptive meshing is a well-established technique to increase computational 
efficiency, particle-activation driven remeshing (Figure 3-11) will be critical to 
multiscale simulation of human thrombosis where the flow field spans the millimeter to 
centimeter length-scale range, whereas the thrombotic processes near the wall involve 
micron-scale boundary layer phenomena. Although the adaptive meshing technique itself 
doesn't present new physics, it allows us to probe larger domains that would otherwise be 
computationally prohibitive. In fact, it would be a necessity if the model were to be 
applied for larger vessel simulations where creation of suitable mesh would be vital to 
numerical computations.  The approach developed also is a versatile and general 
automatic mesh refinement based on evolving platelet deposition patterns, which are not 
known a priori and are affected by flow and, in turn, affect the flow. The adaptive 
meshing approach represents a tractable and robust numerical implementation between 
the Monte Carlo, Neural Networks, and Finite Element calculations of the multiscale 
model. 
In future work, the mesh refinement within clots can be relaxed in regions where 
clot regions become inactive at longer times (full depletion of ADP, TXA2, and 
thrombin).  Even for clots that grow to mm-scale thicknesses to occlude a coronary artery, 
for example, the current mesh refinement algorithm offers significant computational 
savings. 
3.3.2 Thrombin flux case studies     
To simulate thrombin generation, we imposed a time-dependent wall influx with 
the initiation and decaying stage parameterized by two parameters, Tmax and Jmax. A 
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comparison of platelet deposition dynamics is shown in Figure 3-17. For the first case 
representing normal physiology, after an initial lag of 60 seconds, platelet mass started to 
grow linearly to 400 seconds which was consistent with fluorescence measurements in 
experiments. A typical averaged thrombin concentration within the thrombus was found 
to be ~30 nM which agrees with both experimental observations and earlier modelling 
work [28].  Platelets were able to grow a height of ~50 μm in a typical constant blood 
flow simulation. Case II with 5-fold reduction in maximum thrombin signal was also 
studied. Here, a delayed platelet accumulation was observed during the earlier lag phase. 
The thrombus height at 450 seconds of the simulation reached approximately ~45 μm.  
Case III with no thrombin presence predicted a typical thrombus height of 20-30 μm 
which was consistent with our previous work [49].  
Inclusion of thrombin has interesting ramifications compared to other soluble 
agonists. Thrombin has a diffusivity that is much lower than ADP or thromboxane.  Also 
platelet signaling in response to thrombin displays unique properties of fast-on but slow-
off due to PAR-1 and PAR-4 signaling dynamics captured in the PAS training data.  
Differences in calcium signaling due to thrombin (Figure 3-21) highlight these effects.  
Without thrombin present, a clotting event doesn’t cause 60-micron channel occlusion or 
reduction of flow (Figure 3-22). The model predicted a two-fold increase in growth rate 
of thrombus height (~0.13 μm/sec) under the presence of thrombin as compared to the 
case without thrombin.   
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Figure 3-21: Calcium signaling predicted by neural network for platelets exposed to different 
agonists within the thrombus.   
Intracellular calcium is shown for platelets at different layers in the thrombus (A). Inner layer 
platelets (black) that deposited on collagen and were exposed to high thrombin (FIIa) fluxes  
(>10 nM) displayed sustained and high calcium mobilization.  In the next layer, platelets exposed 
primarily to thrombin displayed strong but decaying calcium mobilization (red). Shell region 
platelets exposed primarily to ADP and TXA2 displayed lower and more transient mobilization 
(green). Cumulative calcium level       
0
t
i i baseline
t Ca Ca d    is shown for these three 
different layers of platelets (B). The recent-history activation level within the past 30 sec, 
      ,
t
t i i baselinet t
t Ca Ca d 

  is a metric of the decrease in adhesivity at longer times, 
especially in the outer layer (C). 
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Figure 3-22: Comparison of experiment (A,C) and multiscale simulation (B,D). 
Platelet deposition (A, B) and flow rate (C, D) are shown for pressure relief mode (initial wall 
shear rate, 200 s
-1
) for whole blood flow over high and low TF (10 or 0.1-molecules/μm
2
).  Clot 
morphology and clot height over collagen (located between 100 and 350 m) is shown at various 
times of clotting (E: simulation, top panel; experiment, bottom panel).   
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Figure 3-23: Fully resolved thrombosis for whole blood flow over collagen/TF after 400 sec.  
At constant inlet wall shear rate of 200 s
-1
, the flow velocity becomes quite high in the narrowed 
lumen with peak wall shear rates exceeding ~1000 s
-1
.  Platelet released ADP and TXA2 and wall-
derived thrombin form thin boundary layers as these species elute from the clot and are convected 
downstream.  The simulation predicts the growth of the clot upstream of the collagen, a core of 
highly activated platelets in proximity with collagen, and an outer shell of relatively unactivated 
platelets.   
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3.3.3 Platelet remodeling upon deposition and thrombus morphology 
The remodeling algorithm was designed to capture platelet adhesion behavior 
(VWF translocation followed by integrin mediated firm arrest) without a detailed 
description of single bond kinetics. In the absence of remodeling, the clot structure was 
found to be dendritic with dangling platelet clusters or mechanically-unlikely platelet 
assemblies. One of the reasons for addition of the remodeling was because the clots 
formed in the presence of thrombin were much larger than those studied in our prior work 
where thrombin was absent and dendritic growth was far less developed[49]. 
The remodeling algorithm produced compact clot structures with platelet deposits that 
mimicked the rough modulating thrombus morphology found in experiment (Figure 3-
24).  For an initial wall shear rate of 200 sec
-1
, the predicted rough thrombus surface grew 
linearly with time reaching a thickness of ~50 to 60 microns in 400 sec.   This overall clot 
growth rate of ~ 8 micron/min emerges from the simulation as a clinically relevant and 
experimentally testable metric. 
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Figure 3-24: Comparison of thrombus morphology with and without the remodeling algorithm. 
The remodeling algorithm resulted in physically realistic clot morphology (bottom) as compared 
to the highly dendritic and mechanically unlikely structure obtained without remodeling upon 
adhesion (top). 
 
The multiscale model simulated the contour evolution of platelet mass adherent to 
the collagen surface, the changing wall shear conditions over the rough clot, the 
activation and deposition dynamics of each single platelet and the spatiotemporal 
concentration distribution of important agonists, ADP, TXA2 and thrombin (Figure 3-23). 
The collagen surface created the initial boundary that captured the freely flowing resting 
platelets (note: F(0) = μmin = 0.001 for resting platelets which can increase up to 1000-
fold with activation). The intracellular calcium concentration rises slowly for the platelets 
bound to collagen but remains elevated, as driven by the NN calculator. Additionally, 
exposure to a strong thrombin flux enhanced activation (via PAR1/4 signaling within the 
trained NN calculator) for newly arriving platelets recruited to the growing deposit over 
the collagen.  When the cumulative calcium level reached a threshold of  ξcrit = 10 μM-
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sec at approximately 60 seconds, ADP and TXA2 were released forming a concentration 
boundary layer that worked synergistically with the thrombin in the boundary layer to 
strengthen the platelet calcium signaling. The concentration boundary layer thickness for 
ADP, TXA2 and thrombin extended to 10 μm beyond the clot boundary, which was 
consistent with our previous work [49]. The ADP and TXA2 concentration levels were 
within the effective dynamic range (< 10xEC50) and were significantly higher than those 
in the absence of the thrombin interaction in our prior work because significantly more 
platelets became activated.  The ADP and TXA2 concentrations ranged from 5 μM to 10 
μM and 0.2 μM to 0.3 μM, respectively, in the clotting region for both constant flow and 
pressure relief settings.  
During clotting, the agonist exposure was multicomponent and time-varying. This 
spatial variation in agonist exposure created three different calcium signals (Figure 3-21). 
For the first layer of deposition, the platelets exposed to both collagen and thrombin at 
the bottom surface became the most activated due to the sustained calcium mobilization 
induced by these two potent agonists. For the next few levels that were about 5 to 20 μm 
above the surface, the platelets were exposed to a sustained high level of thrombin 
stimulation especially before ADP and TXA2 were produced. The calcium signal rose 
rapidly but decayed afterwards. For the outer most layers (>20 μm above the surface), 
platelets were mostly exposed to high ADP and TXA2 concentrations but relatively low 
thrombin stimulation, which was reflected in a less pronounced increase in calcium signal 
followed by a similar decaying process as those undergoing major thrombin influence 
(typically in the 5 −20μm layer). 
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Another emergent feature of the simulation was that arriving platelets could 
facilitate growth at the front of the clot in the upstream direction (Figure 3-23).  The 
accumulation of upstream platelets was consistent with experimental observation of clot 
growth within the microfluidic clotting assay.  As platelets in the near wall layer were 
convected by the flow in the simulation, the approaching platelets added to the front of 
the immobilized platelet deposit, even in the absence of underlying collagen. 
3.3.4 Constant Flow and Pressure Relief 
In both experiments and corresponding simulations, two different flow modes 
were considered: the constant flow rate mode and the pressure relief mode (Figure 3-10).  
In the constant flow rate mode, blood was perfused at a constant flow rate to ensure the 
initial inlet wall shear rate of 200 sec
-1
 was maintained during the entire course of the 
experiment and simulation. This is an easily and commonly achieved experimental 
condition by setting a constant pump speed at the start of the experiment, but this flow 
mode is not physiological. There was a considerable increase in wall shear rate along the 
platelet-fluid boundary in the simulation. As the thrombus started to grow to the point 
where no more platelets could form a stable bond with the existing thrombus, the shear 
rate became highly variable along the thrombus contour and reached a maximum shear of 
about 3000 sec
-1
 (a pathologically high shear rate).  At approximately 350 sec, the platelet 
accumulation rate was significantly reduced.  At 400 sec, the thrombus grew to 
approximately 85% occlusion with a maximum height of about 50 μm.   
However in the body, as a blood vessel becomes fully occluded, flow is diverted 
to other vessels.  This is achieved experimentally using microfluidics in the pressure 
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relief mode.  For paired channels (one with blood treated with EDTA to quench all 
clotting), blood flow was diverted to the open EDTA-channel as platelets accumulated in 
the thrombotic active channel.  Initially, the wall shear rates along the platelet-fluid 
boundary grew similarly as in the constant flow mode (Figure 3-25) because a partial 
blockage creates little pressure drop.  Only at times longer than 300 sec did the growing 
platelet mass cause a significant pressure drop and thus reduce flow in both the 
experiment and in the pressure relief mode simulation (Figure 3-22).  As the channel 
approached full occlusion, the maximum shear rate experienced by the platelet mass was 
~1000 s
-1
, considerably less than for the constant flowrate case. Because the unbinding 
kinetic rates were shear-dependent, the pressure relief mode allowed the platelet mass to 
grow to full occlusion.  Another noticeable feature for the pressure relief mode was that 
the agonist concentration was much higher than those under constant flow settings at the 
later stages of aggregation. This was also expected as the flow was essentially stopped at 
the later stages approaching full occlusion as resistance to flow caused by the thrombus 
increased. With convective dilution significantly reduced, the agonist transport was 
mainly diffusive, leaving a much thicker boundary layer than the one with constant flow 
rate. We have previously observed in experiments that autocrinic effects through ADP 
and TXA2 can be particularly potent the moment when flow stops [18], effectively 
leading to a flow-dependent quorum sensing mechanism. 
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Figure 3-25: Shear distribution for constant flow and pressure relief settings. 
 
Also, the multiscale model was able to capture platelet deposition dynamics and 
morphological information under different levels of tissue factor stimulation consistent 
with microfluidic experiments conducted under pressure relief conditions (Figure 3-22, 
3-26). At nearly complete occlusion, a total of about 1100 and 1300 platelets were 
deposited on the collagen patch for 0.1 molecules/μm
2
 (low) and 10 molecules/μm
2
 
(high), respectively, which corresponded to about 300,000 platelets in a 0.0045 μL 
volume [(250μm+50μm)-long x 250-μm wide x 60-μm high], or ~200-fold the 
concentration of platelet rich plasma (PRP) which has a concentration of ~300,000 
platelets/μL.   
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Figure 3-26 Evolution over 400 sec of flow and thrombosis (ADP, TXA2, thrombin) at constant 
flow rate (A) or pressure relief mode (B).  Initial inlet wall shear rate = 200 s
-1
. 
 
In both simulation and experiment, after a lag of about 50 sec, the thrombus mass grew 
linearly from 50 sec to ~400 sec, for both high and low tissue factor level (Figure 3-22). 
At low TF levels, a 5-fold decrease in maximum thrombin flux was chosen. The typical 
maximum thrombin concentration (Figure 3-23) reached ~90 nM and ~20 nM for high 
and low TF cases, respectively, which was within an expected range of thrombin 
concentration reported for experiments [20,58,76].  Higher levels of TF saturated the clot 
thrombin level. This threshold behavior in thrombin generation was also reported in other 
multiscale models with coagulation cascade embedded. [28,48]   For the low and high TF 
cases in pressure relief mode, the simulated instantaneous volumetric flow rates matched 
accurately with the experimental measurements (Figure 3-22). The multiscale model was 
able to predict important outcomes such as occlusion time for both low and high TF 
levels. Under high TF condition, the channel was occluded at around 450 sec, about 100 
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sec faster than under low TF stimulation. Individual clot morphology was also correctly 
predicted by the model.  As seen in both simulation and experiment, the clot width 
extended upstream and downstream of the initial 250 μm collagen patch (Figure 3-22). 
Tissue factor level did not seem to have a substantial effect on clot morphology but did 
affect the thrombus growth rate.  Figure 3-22F shows a typical 2D thrombus evolution 
profile under high TF condition, which compares well against the experimental height 
distribution averaged over a total of 40 confocal scans of the cross-section of the 3D 
channel (Figure 3-22C).  At an earlier stage of clotting, platelets were shown to form 
individual clumps with sizes ranging from 20 μm to 60 μm that were quite consistent 
with individual line scans.   
3.3.5 Agonist study 
The model was also applied to different pharmacological conditions to study the role of 
ADP, TXA2 or prostacyclin-like signaling alters platelet deposition dynamics. In a 
sequence of simulations, the concentration of each agonist, ADP or TXA2, was set to zero 
to isolate the effect of one agonist as compared to the control case. In addition, the 
prostacyclin analog iloprost was set to maximum level to simulate the case of strong IP 
receptor stimulation. These computational conditions correspond precisely to 
microfluidic experiments using MRS2179 for P2Y1 inhibition (removal of ADP), aspirin 
for COX-1 inhibition (removal of TXA2) and ilopost for IP receptor stimulation. Figure 
3-27 shows a comparison between the simulated platelet number and experimental 
fluorescence for the three agonist conditions in contrast to the control case under the low 
TF stimulation. Iloprost had the strongest effect by strongly inhibiting the platelet 
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function in the experiment and in the simulation. Removing ADP also significantly 
reduced platelet accumulation by almost 50% in both experiment and simulation. 
Inhibition of TXA2 had the least pronounced effect, as expected for aspirin, which is a 
less potent antiplatelet agent. There was considerable agreement between experiments 
and simulations for different agonist conditions in the presence of wall generated 
thrombin, which represents an experimental validation of the functional forms of the 
adhesion dynamics which centered on the calcium signal as a metric and the thrombin 
wall flux used in the simulation. 
 
 
Figure 3-27: Comparison of experiment (A) and multiscale simulation (B) for different agonist 
conditions.  
Measured platelet deposition in the presence of aspirin, MRS 2179 and iloprost treatment (A) and 
corresponding multiscale simulation (n=8) with no TXA2, no ADP and iloprost stimulation (B). 
3.4 Discussion 
A major challenge in modeling blood clotting is the strong coupling of 
intracellular signaling, extracellular protease cascades, hemodynamics, and 
multicomponent mass transfer.  Currently, massive computational expense would be 
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associated with: (i) single molecule resolution of adhesion dynamics, (ii) detailed bottom-
up models of single platelet signaling, (iii) wall-initiated thrombin generation, and (iv) 
complex three dimensional pulsatile flows.  To facilitate multiscale simulation of clotting 
in two dimensions at reasonable computational cost, we implemented cell activation-
driven adaptive meshing (Figure 3-11), a rapid calculation of aggregate restructuring 
(Figure 3-18), a model of thrombin generation implemented as a boundary condition 
rather than as additional governing equations in the domain (Figure 3-7). Additionally, a 
data-driven NN model of platelet calcium mobilization used pairwise agonist scanning 
(PAS) (Figure 3-2), allowing a very rapid calculation of “average healthy human” 
platelet response to multiple, time-dependent stimuli.  Together, the resulting 
computational efficiency and the multiscale model structure using PAS-NN allows 
platelet phenotyping for patient-specific simulation of thrombosis. Also, the stochastic 
nature of the LKMC allowed the evolution of rough thrombus contours as observed in 
real clotting processes, a result impossible to obtain with continuum models.  
The model predicted platelet calcium responses based on spatiotemporal 
exposures and location within the clot (Figure 3-23).  Platelets in contact with collagen 
have sustained calcium mobilization.  Platelets deposited subsequently become activated 
to a lesser extent than the first layer of platelets with the last arriving platelets displaying 
the least activation driven only by eluting ADP and thromboxane (Figure 3-21).  These 
differences in calcium signaling rate emerge from the multiscale simulation and represent 
tissue-scale gradients that may underlie the observed core-shell architecture observed in 
experiments in vivo in mice [77] and with human blood ex vivo by Welsh et al. [46].   
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To simulate experimental studies in arterials (~ 30 μm diameter) or microfluidics 
(60 μm channel height) with wall-derived TF, imposing a boundary flux parameterized 
by key parameters, maximum signal and time to reach maximum represents a suitable 
coarse-graining approach.  Along with the aggregate restructuring model, the multiscale 
model predicted clot morphology, upstream clot growth, clot growth rate and occlusion 
time for the cases of high and low TF stimulation (Figure 3-22, Figure 3-24).    
The use of apparent kinetics for cell-activation dependent binding/detachment and the 
platelet restructuring algorithm reduced by at least ~10
3
-fold the numerical burden of 
single cell/single molecule resolution via adhesive dynamics simulations.  Improved 
resolution of concentration boundary layers over a rough boundary was achieved through 
the use of adaptive remeshing without a significant increase in computational burden.  
The remeshing algorithm used a global influence function to distinguish regions with 
sharp gradient change from large regions of unreactive blood flow outside the boundary 
layer. This feature of the remeshing algorithm will be essential for larger, three 
dimensional simulations of coronary or carotid artery thrombosis where the flow field is 
substantially larger and more complex. This remeshing algorithm can be readily applied 
to a variety of hierarchical systems biology problems with a developing boundary 
layer/reaction front that is driven by discrete cell processes in the presence of prevailing 
transport physics.   
This is the first report of a data-driven platelet model of thrombosis under flow in 
the presence of surface collagen/TF, and convective-diffusive transport of ADP, TXA2, 
and thrombin.  Importantly, the central predictions of the simulation were tested against 
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microfluidic experiments conducted with human blood under the exact conditions of the 
simulations.  Two types of operational modes, constant flow and pressure relief were 
studied.  There was considerable agreement between experimental measurements and 
numerical prediction on platelet morphology and thrombus formation dynamics. Clearly, 
clot growth rate and final size were regulated by prevailing wall shear rates.  Under 
constant flow for constant inlet wall shear rate of 200 sec
-1
, the thrombus typically 
reached ~85% occlusion before the single platelet deposition on-rate was balanced by the 
single platelet erosion off-rate from the surface. Although the multiscale model did not 
treat whole-clot fracture from the surface (embolism), the steady state clot thickness of 50 
μm (~85% occlusion of the 60-μm channel) occurred when the wall shear rate 
experienced on the clot surface exceeded ~6000 s
-1
 and the net addition of platelets was 
zero (not shown). More interestingly, the model was able to predict platelet deposition 
dynamics for a set of clinically relevant pharmacological conditions. One of the key 
features of this multiscale model was the use of intracellular calcium signaling to 
simulate cell-cell interactions. This signaling approach was shown to have excellent 
agreement with microfluidic experiments conducted on healthy donors in response to 
various blood modulators (Aspirin, MRS 2179, iloprost). This model has shown the 
ability to be used as a reliable prediction of blood function under hemodynamic 
conditions. 
In future work of thrombosis in arterial stenoses, the effect of extreme shear rates 
on von Willebrand structure and function [78,79] will require consideration and 
parameterization.  Additionally, numerical integration of the local instantaneous thrombin 
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concentration provides a metric for estimating fibrin monomer generation/transport as 
well as fibrin formation.  Fibrin, in turn, would quench platelet detachment rates.  Fibrin 
deposition has been observed in the region closest to the TF-laden surface and to display 
spatial variations, typically with more fibrin appearing downstream [20].  In summary, 
flow affects clotting and clotting affects flow.  The multiscale model honors this coupling 
by deploying data-driven kinetic information, full bottom-up reaction networks, and fully 
resolved hemodynamics and transport phenomenon.   The computational efficiency of the 
algorithm is directed at supporting full simulation of thrombosis using patient-specific 
blood phenotypes in relevant arterial vasculatures. 
3.5 Conclusion 
The multiscale model represents the first computational model of thrombosis that 
incorporates a prediction on the boundary thrombin flux supported by quantitative 
experimental measure. Additionally, the model predicts a peak thrombin flux on the order 
of 10
-12
 nmole/μm
2
-sec testable by experimental measurement for a TF rich surface 
exposed to flowing blood. This comprehensive model is able to study the full aspect of 
platelet motion, biological signaling, platelet signaling, and transport of soluble species 
and make quantitative prediction on the thrombus growth under the influence of various 
cardiovascular modulators. To summarize, pairwise agonist scanning (PAS) experiments 
were performed on 10 healthy donors (50% male) to train a neural network ensemble 
with 6160 calcium traces to predict calcium response for an average healthy person. The 
neural network ensemble combining 100 individual NNs from 10 donors was 
incorporated into the multiscale model to predict platelet activation. An effective 
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boundary flux term was imposed to coarsen-grain the entire coagulation cascade. 
Thrombus growth dynamics can be predicted by the multiscale model and were compared 
against microfluidic experiments on healthy human blood conducted under identical 
conditions. The experimental results and numerical simulations agreed on both constant 
flow and pressure relief conditions. More importantly, the model was able to replicate the 
thrombus growth dynamics in the absence of ADP, TXA2, which are the common drug 
targets for thrombosis inhibition. The future work is to apply the multiscale model to 
study the hemodynamics and blood biology for patients with coronary artery diseases. 
This would require a new set of neural network model capturing the calcium response for 
real patient blood. Also it is also possible to apply the model to extended domain 
representative of cardio-vasculature of real patients. This model will lay the foundation 
for real-time prediction of the coronary artery thrombosis which is of vital importance in 
clinical studies. 
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Figure 3-28: Connection between experimental measurement and numerical prediction 
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Chapter 4 : Platelet aggregation under stenotic conditions 
4.1 Introduction 
Thrombosis refers the pathological process of excessive clot formation inside the 
blood vessel, obstructing blood circulation through the human body. The constriction or 
obstruction in the blood vessel interferes with the normal circulation, leading to 
temporary deficiency in oxygen supply. Almost all cardiovascular diseases such as 
ischemia, angina, etc. originate from disturbed blood recirculation due to constructed 
vasculature. Atherosclerosis for instance, is a type of coronary artery diseases that results 
of plaque buildup consisting of fatty substances, cholesterol and other cellular waste 
products, in the inner lining of an artery. The plaque formation creates stenosis in the 
blood vessel, altering the hemodynamics and biological signaling. The pathological 
plaque may induce the hardening of artery or even blocking the blood flow entirely. More 
importantly, hemorrhage and thrombus formation typically coincide with the occurrence 
of plaque formation in the coronary arteries. If either of these occurs and blocks the entire 
artery, a heart attack or stroke may result. High-grade stenosis especially occurring near 
the heart may result in sudden cardiac arrest, causing almost instant death. Each year, 
there are approximately 8.6 million incidents of myocardial infarction worldwide. There 
has been excessive research work being conducted all over the world for early detection 
and prevention of coronary artery diseases. 
 The blood flow usually coupled with complex vortex patterns in the stenotic 
vessel is very distinct form what is observed in the normal arteries. The complex patterns  
Also, stresses and resistance to flow are much higher in stenosed arteries in comparison 
to the normal ones. Having knowledge on flow parameters, such as velocity, flow rate, 
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pressure drop will aid bio-medical engineers in developing bio-medical instruments for 
treatment (surgical) modalities.  
There have been numerous efforts to study platelet aggregation under stenotic 
conditions. Tovar-Lopez et al. [80] used a microfluidic platform to study the relation 
between the blood flow and platelet aggregation under micro-gradient conditions. A 
micro-scale stenosis was created within the microfluidic devices and the dynamics of 
thrombus formation at the back-end of the stenotic apex. Soares et al. [81]used a 
dissipative particle dynamics approach to simulate platelet suspension flowing through a 
three-dimensional stenotic channel. Bark et al. proposed a platelet transport and 
aggregation model at high shear over a stenotic channel representative of a coronary 
artery. The proposed binding kinetics was entirely dependent on hemodynamics without 
consideration of platelet biology and blood coagulation. Yazdani et al. [50] proposed a 
multiscale model with the interaction between platelets defined by an empirical Morse 
potential. The model was also applied to study clot formation within a microscale stenotic 
channel.  
In the previous chapter, a multi-element lattice Kinetic Monte Carlo model was 
developed and demonstrated to provide an accurate prediction on the dynamics of 
thrombus formation under different tissue-factor stimulation levels and was able to depict 
evolution of thrombus morphology as a function of time. The rest of the chapter will be 
focused on adapting the current model to simulate platelet aggregation within a channel 
representative of the size of a coronary artery. The model will also account for platelet 
signaling biology with the previously trained NN.  
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4.2 Stabilization techniques for Finite Element method 
One of the most encountered problems in engineering is the numerical solution of 
the famous convection-diffusion-reaction equations especially for the case of time-
dependent transport of chemically reactive specifies. One inherent defect in finite element 
method is its lack of stability for problems where the diffusive contribution is several 
orders less than the size of the convective field. Especially for the transport of reactive 
specifies under a convection-dominated setting with even complex vertex patterns, the 
oscillating nature of the vanilla FEM solution becomes so prominent that the accumulated 
errors quickly deteriorate the concentration field, rendering the entire solution unphysical. 
Another marked feature of solutions for convection dominated problems is the presence 
of sharply distinct concentration layers that aggravates the issue of stability. Stabilization 
techniques have been implemented within the FEM scheme to mitigate the presence of 
spurious oscillation. [82] 
The followings are adapted from [82] which describes some useful techniques dealing 
with such concern.  
4.2.1 The Streamline Upwind Petrov-Galerkin (SUPG) method 
Consider the scalar version for the time-dependent convection-diffusion-reaction 
equation for concentration field u with diffusivity  , convective field b , reaction c  and 
load factor f .  
tu u u cu f     b       (4-1) 
The fractional time-step discretization gives: 
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   (4-2) 
The backward Euler is obtained when 1 4 2 31, 0       . 
The Crank-Nicolson scheme is obtained when 1 2 3 4 0.5       . The effective 
coefficients for diffusion, convection, convection are  
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b        (4-3) 
Finite element methods employ a finite dimensional space 
hV V   which aims to find 
h h
ku V  such that for all functions 
h hV  based on triangulation hT  ,  
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           
b
b
(4-4) 
The streamline upwind Petrov-Galerkin (SUPG) method was first proposed by Brooks 
and Hughes [83] for solving advection-diffusion and Navier-Stokes equations. The 
technique has found its popularity among many other problems which require 
considerable stabilization to correct for the effect of strong convection dominance. The 
idea of the SUPG method is to add a consistent diffusion term in the streamline direction 
to the original formulation  ,
h
h
k K
K T
residual v

 C  , where  k  is a set of parameters 
depending on the element K,  , ,  is the inner product in 2L   and C  denotes the 
convection. The new formulation is  
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   (4-5) 
The success of the SUPG formulation lies in the choice of the parameter K . Here, we 
introduce three different formulae for the SUPG parameter for the time-dependent case. 
Codina [84] proposed to set the parameter as 
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  ,    (4-6) 
Where Kh  is an appropriate measure for the size of the element K. 
Franca and Valentin [85] proposed the following for linear finite element: 
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Knopp et al [86] proposed the following for bi-linear finite elements: 
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     (4-9) 
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Note for the case where 2
2
0, 0, K kc h t   b  , 1
Cod FV KLR
K K K     . 
It was recommended that the measure of the element size Kh  should be chosen as the 
length of the mesh cell in the direction of the convection. The SUPG method generally 
leads to stable discretization regardless of the length of the time step, however in some 
cases spurious oscillations are still present.  
4.2.2 Spurious Oscillations at Layers Diminishing (SOLD) methods 
Originated from the idea of adding artificial diffusion, SOLD methods have been 
developed to reduce spurious oscillations that might occur in SUPG formulation. The 
reviews show that several classes of SOLD method all have their strength and pitfalls and 
there is no clear proof whether one method is superior for certain problems. 
The family of SOLD methods adds an extra diffusion term  ,h harti ku v    . For isotropic 
diffusion, the same term with a particular artificial diffusion coefficient arti isotropic    is 
added. To determine the coefficient isotropic , there are several functional forms. 
 
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2
2
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
       (4-10) 
The parameter   depends on the scaling vector 
 
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2
Residual h h
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h
u u
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u

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 

z  . 
The definition of   is proposed by several different schemes. 
The first scheme is 
  max 0, hK k   z .       (4-11) 
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Here K  is the chosen SUPG stabilization parameter. Notice the parameter   is different 
from zero only where the scaling vector produced a different SUPG parameter than the 
corresponding convective vector.  
The second scheme is  
 
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h h
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C u
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.   (4-12) 
For anisotropic SOLD methods, the extra term becomes  
   ,h hanistropic ku v  C  ,       (4-13) 
where    
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One proposition for the parameter anistropic  is 
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 ,     (4-15) 
where C  is an empirical constant (usually ~0.6), ( )diam K  is the diameter of the mesh 
element. John e al. [87] proposed a similar form, 
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   (4-16) 
Almost all SOLD methods require the computation of residual which takes the form, 
 1k k k k k k k ku u t u u cu t f       b  .   (4-17) 
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Since the parameters depend on the solution at the current time step, an iterative solver 
has to be applied to solve the non-linear formulation the altered SOLD formulation. The 
computation time therefore is much larger than the linear case. 
4.2.3 FEM-flux corrected transport (FEM-FCT) schemes 
FEM-FCT schemes have been developed in [88-91] to solve the spurious oscillation 
problem. To start, the matrix form of the FEM equation is  
   1 2 1 3 1 4C k k C k k k k k kM t A u M t A u t f t f                (4-18) 
The first step is to induce that if the maximum principle holds for the continuous equation, 
then this should also hold for the discrete equation. A sufficient condition for a matrix to 
be an M-matrix is that all diagonal entries are positive, all off-diagonal entries are non-
positive and the row sums are positive. Thus, we can set the following: 
 
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  ,    (4-19) 
where N  is the number of degrees of freedom. The row and column sums of matrix D 
are zero. The matrix L contains all non-positive off-diagonal entries. The matrix LM  is a 
diagonal with the entries equal to column sums of the mass matrix. 
The matrix form of the FEM now becomes: 
   1 2 1 3 1 4L k k L k k k k k kM t L u M t L u t f t f                (4-20) 
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The solution does not show spurious oscillations but may incur smeared layers. 
The second step of FEM-FCT schemes is modify the right hand side of the above 
question to handle unnecessary smearing caused by excess diffusion. 
     *1 2 1 3 1 4 1,L k k L k k k k k k k kM t L u M t L u t f t f f u u                 (4-21) 
The weighting vector  * 1,k kf u u   is dependent on the residual vector 
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 (4-22) 
To define the weights, the element-wise residual can be written as 
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And 
 * 1
1
,
N
k k ij ij
j
f u u r

  with weights  0, 1ij  . 
As the residuals depend on the solution at the current instant, a non-linear scheme was 
proposed. The non-linear FEM-FCT scheme computes an explicit low order solution u  at 
the time 
1 1k k k
t t t     .  
For the backward Euler method, 1ku u  .  
For the Crank-Nicolson method,  11 1 1
2
k
k L k k
t
u u M Lu f  

   .  
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For linear FEM-FCT scheme, the dependence on ku is removed by adopting a low-order 
approximation usually forward Euler scheme from the intermediate value 
 1/2 1 / 2k k ku u u   . 
The residual flux is computed as: 
       , , 1, 1, 1 , , 2 1, 1,ij ij k i k j ij k i k j k ij k i k j k ij k i k jr m u u m u u t d u u t d u u             (4-24) 
Using the forward Euler approximation of the intermediate, we have 
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  (4-25) 
For computing the weights, the following Zalesak’s algorithm [92] is used. 
1. Compute  
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4. Compute 
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      (4-29) 
4.3 Simulation methods 
The multiscale platelet aggregation model described in the previous chapter was 
able to simulate thrombus growth on a microfluidic chip. To adapt the model that were 
specifically designed for microfluidic settings to the case of coronary artery simulation, 
the capacity of the model has to be upgraded as the simulation domain increased 500 
folds. (Figure 4-1) 
 
Figure 4-1 Comparison of the microfluidic channel and coronary artery 
Top left and right represent the 8-channel microfluidic device and simulation domain for 2D 
microfluidic model, respectively. Bottom left and right show the cardio-vascular recreated from 
CT imaging and the LKMC simulation domain for the stenotic channel. Reactive collagen patch 
(potential rupture) was shown in red. 
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In order to predict the thrombus size and shape under physiological conditions 
consistent with coronary artery diseases, the model has to be extended stenotic settings 
where complex flow patterns are expected. A noted difference in length scale from the 
size of a platelet (~ 3μm) to the typical diameter of a coronary artery (~ 3mm) adds to the 
difficult of coupling between the underlying modules as different levels of accuracy have 
to applied to a specific sub-problem of the artery thrombosis.  
The following sections are devoted to descriptions of modifications on the 
previous microfluidic model.  
4.3.1 Creation of stenosis geometry 
The coronary artery is modelled as a rectangular channel with diameter 3mm and 
length 20mm (in comparison with the previous microfluidic channel 500μm by 60μm). A 
symmetric pair of sharp Gaussian stenosis was placed of the regular channel at a region 
close to the inlet. The definition requires three key parameters: center  location of center, 
  standard deviation of the Gaussian obstacle, sth height of the stenosis. In this work, 
only symmetric stenosis is considered. The severity of the stenosis is defined as the 
2 sth
Diameter
. The stenosis in Figure 4-1 is created by setting 2mm  , 300 m  , 
1000sth m with 66.7% stenosis. The reactive surface where collagen is exposed is 
located at the backside of the stenosis at the bottom. The length of the reactive patch is 
set to 1250μm, creating a sufficient platform for initial platelet recruitment and activation. 
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4.3.2 Lattice Kinetic Monte Carlo for stenosis simulation 
The stenotic region is also discretized by uniform squares as well. Rather than 
allowing one platelet to occupy several lattice spaces, each platelet occupies only one 
lattice space (i.e, 1  ). This is a trade-off between the accuracy of the LKMC 
propagator and simulation capacity. In comparison to the previous case where the number 
of platelets increases from ~20 initially to ~1000 for fully occulated, the stenosis 
simulation typically involves as many as 10000 particles, increasing the computational 
cost of LKMC. Furthermore, the space complexity also scales with the number of 
particles as the location, activation, calcium states, and reaction rates have to be recorded 
and updated after each update. Therefore, the simulation cost for the LKMC module will 
increase significantly for the stenosis case.  
Utilizing the symmetric feature of stenotic channel, the LKMC algorithm can be 
further optimized by limiting the domain of interest to the bottom half the channel. In 
contract to the microfluidic channel, the flow magnitude under physiological condition 
for the stenotic channel is significantly larger thereby creating a layer separation between 
the region near the wall and the middle section. The flow acceleration in the narrowed 
region increases the rates of the convection along the flow direction all the way 
downstream. The only force for a platelet to traverse the highly convective field is 
through diffusive or drift force which is merger compared to the resistance created by the 
flow field. In fact, one numerical experimental only 1 out of 10000 particles introduced at 
the top half of the simulation domain was able to traverse to the bottom half of the 
simulation domain. Furthermore, only considering the bottom half of the domain largely 
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reduces both the memory burden and simulation time. It is not only efficient but also 
necessary to make this assumption to optimize the LKMC algorithm. 
4.3.3 Lattice Boltzmann for complex flow recirculation 
 Rooted from kinetic theory and cellular automata, LB equation is an 
approximation to the continuum Navier Stokes equation which captures all kinds of 
complex patterns. The simplicity of formulation and its versatility explain the rapid 
expansion of the LB method to applications in complex and multiscale flows, including 
the study of hemodynamics and blood recirculation. It is particularly to understand the 
interplay between the convective flow environment and the mechanical and biological 
phenomena associated with the platelet accumulation process. Recent advancement in 
large vessel simulation utilizes massive-parallel computing schemes to further extend the 
frontier to the realm where pulsatile blood flow simulation for a patient-specific cardio-
vasculature becomes a possibility.[93]   
Similar to the LKMC module, the gridding in the LB module has to be coarsened 
as well. More importantly, in order to account for the entire details of the recirculation 
zones, the boundary conditions have to be set at the extended exit far from the stenosis. 
The sharp obstacles occlude almost half of the channel and the momentum of the 
accelerated flow through the narrowed regions creates large eddies at the post-stenotic 
region. It is customary to set the boundary conditions in LB simulation according to 
either a well-defined flow profile or a pre-determined pressure condition. One simple 
flow condition considered is the quasi-steady flow where the flow is assumed to be a 
constant parabolic flow. The same flow conditions are applied at both the inlet and the 
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outlet at the fully developed location. Depending on the maximum axial flow and vessel 
geometry, the flow pattern at the post-stenotic apex varies from the unidirectional to 
swirling. The size of the vortex accumulated along the reactive patch largely depends on 
the momentum of the flow. If the flow rate reaches ~3cc/s (pathological), the vortex size 
could reach as long as ~ 6mm, which further extends the simulation domain. Therefore, it 
is numerically prohibitive to obtain a micron-scale resolution of the flow field. Rather 
than overlaying the LB domain over the LKMC domain with uniform spacing of 3μm, 
the LB domain has to be coarsened as well. The thrombus morphology is also smeared, 
where an interpolation process is adopted. In fact, since the hydrodynamic interaction 
between platelets and the fluid is ignored, requiring platelet-level accuracy is unnecessary.   
4.3.4 Stabilized finite element calculation  
 It is well-known that excessive convection term in the FEM assembly can cause 
stability issues. Various stability techniques have been discussed in the previous section. 
The complex flow pattern for the stenotic channel also causes spurious oscillations that 
can contaminate FEM solution.  One thing to note is that the transport of agonist under 
vortex condition should take into account the flow feature as well. For mild flow without 
flow reversal, the transport for reactive species is almost identical to the microfluidic case 
except the release of agonists occurs at a higher altitude. For recirculating flows, the 
agonists released will follow a similar recirculating pattern. It is imperative that all the 
recirculation regions be included to satisfy meaningful boundary conditions for agonist 
transport. However, rather than simulating the entire flow domain as in LB, we only need 
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to simulate of the bottom half of the domain due to the strong convective field limiting 
the transport of agonist as well.  
 An unstructured triangular mesh with refinement for the clotting region in the 
vicinity of the post-stenotic section is applied. For the current study, the variation in the 
concentration field is not localized to the clotting region. Therefore, the adaptive mesh 
approach is not adopted. A SUPG-based FEM algorithm is applied to ensure stability of 
the solution. The reactive collagen surface was assumed to be at the post-stenotic arc 
between 2150μm and 2700μm. The same thrombin flux as the microfluidic model was 
applied. 
4.4 Results 
4.4.1 Flow within a stenotic channel 
The same parabolic flow profile with maximum axial velocity equal to 2.2cm/s 
(physiological flow) was used as boundary conditions for LB at both the inlet and the 
outlet. The resultant flow field was shown in Figure 4-2. A prominent flow recirculation 
zone was developed at the post-stenotic segment under the physiological flow conditions. 
The axial velocity distribution taken at x=0.2cm, 0.4cm, 0.6cm, 0.8cm, 1cm was shown 
in Figure 4-3. The mass momentum of the flow was conserved at all locations. Flow 
reversal was seen at x=0.4cm, the vertical line cutting through the vortex. The flow then 
became unidirectional at x=0.6cm, while gradually returning its fully developed and 
relaxed state x=1.0cm. By connecting all locations with zero flow, the flow separation 
line was found to be in the vicinity of the reactive patch initially. With the accumulation 
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of platelets onto the collagen patch, the flow separation would move further upward, 
altering the dynamics of transport of both free platelet and agonists such as ADP, TXA2. 
The flow in the x-direction reached its maximum and was almost uniform with large 
momentum at the apex of the stenosis. In comparison to the unidirectional flow in 
microfluidic systems, one immediate consequence of the stenotic vortices is its presence 
of layer-separated flow. The one-directional convection in the x-direction strongly 
dominates the motion of platelets above the stagnation point, while there is considerable 
backward motion pertaining to movement of vortex blow the stagnation point. 
Apparently, the occurrence of vortices is largely dependent on the magnitude of the flow 
and the geometry of the stenosis. A similar parabolic flow with unphysiologically low 
maximum axial velocity (0.8cm/s) would lead to a unidirectional flow profile without the 
presence of vortices. These vortex features were often witnessed in the narrowed 
coronary arteries of patients experiencing chest pain and shortness of breath.  
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Figure 4-2: Flow field with vortex feature obtained with maximum axial velocity at the inlet = 
2.2cm/s  
 
 
Figure 4-3: Axial velocity distribution at the different locations  
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4.4.2 Platelet trajectory under stenosis 
The platelet trajectory test was performed by introducing one single platelet to the inlet at 
a specific height. The only events of the platelet are the RBC-enhanced diffusion and 
convection. The stochastic trajectory of platelet motion determined by the LKMC 
algorithm equipped with pre-calculated stenotic channel flow until the platelet exited the 
domain. The test aimed to explore the motion of platelets in the absence of surface 
reaction. A clear discrepancy in trajectory of motion was witnessed for platelets at 
different locations (Figure 4-4), demonstrating different hitting dynamics than the 
unidirectional flow. Platelets that were placed near the vessel wall (within 150μm) before 
climbing up the arched stenosis, typically ends up within the swirling vortex.  5% of the 
200 tested near-wall platelets lingered within the simulation domain for more than 5 
seconds before exiting the channel. For platelets that were 300μm above the wall, a 
divergence in trajectory of motion. Approximately 30% of the particles were trapped into 
the swirling flow while the rest traversed the channel above the stagnation line. As the 
initial axial location moved further toward the center, platelets were less likely to hit the 
post-stenotic arc, thereby not likely to contribute to a clotting event. Therefore, we can 
conclude most clotting events were triggered by platelets that were initially near the 
vessel (within 300μm). This trajectory test further confirmed the proposition that there 
was a pronounced difference in platelet motion due to hemodynamics of stenosis. Under 
this specific geometry, platelets can reach the reactive patch either by directly attacking 
the top segment above the flow separation point or going through a tortuous route to 
attack the back side of the path from the bottom upwards. 
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Figure 4-4: Trajectory of platelets at different axial locations 
 
4.4.3 Thrombus development under stenosis 
A thrombus development simulation was performed on a 66.7% stenotic channel by a 
setting a thrombin flux signal similar to that defined in the microfluidic case. Figure 4-5 
illustrates the evolution of thrombus contour to 600 seconds. The resultant thrombus 
morphology agreed well with experimentally observed clot shape on a microscale 
platform. [80]  Initially the platelets were almost uniformly along the reactive patch 
surface, creating a protruding thrombus. Gradually more platelets were accumulated near 
the stagnation point of the flow. The flow separation line also carved out the shape of the 
thrombus. The shear rate at the back side of the stenosis apex was initially within the 
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venous shear regime (<3000 s
-1
). Therefore, the same binding kinetics as the microfluidic 
case was assumed with detachment rate increasing exponentially with shear rate. The 
number of bound platelets increased linearly with time initially and gradually leveled 
when the thrombus reached the critical shear when the detachment rate dominated. A 
similar thrombus growth rate (~0.10 μm/s) as the microfluidic case was seen. The two 
different hitting mechanisms were also reflected in the thrombus morphology. The top 
segment (within 150μm from the tip of collagen patch) was mainly formed by direct 
contact with upstream particles travelling along the arc, while the bottom segment was 
formed by platelets undergoing the recirculating motion. The shear near the top segment 
was higher than that near the bottom, which limits the excessive buildup of upstream 
platelets.  
At 500 seconds, the thrombus grew to a significant height such that the flow separation 
line started to shift, altering the transport of both platelets and diffusible species. This is 
another example showcasing the interaction between platelet mass and the flow could 
impact the entire aggregation process. One thing is note is that the high-shear (>6000 s
-1
) 
binding kinetics caused by vWF was not considered. Typically, vWFs will unfold on the 
platelet surface at high shear rate to initiate further binding mechanism, which may lead 
to occlusion of the vessel at some point. 
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Figure 4-5: Development of thrombus at the post-stenotic arch 
Bond platelets are shown in red, free platelets in blue, wall in yellow, collagen in purple. 
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4.4.4 Transport of diffusible agonists under stenosis 
An interesting two-stage behavior was seen for the transport of ADP, TXA2 and IIa. 
(Figure 4-6) At the initial stage less than 200 seconds, thrombin was being released to 
the system through wall flux along with the release of secondary agonists ADP and TXA2 
by activated platelets. The agonists were localized near the surface of the clot, while only 
a small proportion reached the vortex zone before exiting the domain. As the thrombus 
started to grow, the frontier of the concentration boundary layer also progressed, thereby 
gradually approaching the vortex region. When the thrombus started to shift the flow 
separation line at 500 seconds (Figure 4-5), the transport dynamics switched from a 
localized scheme to spread all over the vortices. At the instant of shift of stagnation line 
at 500 seconds, the agonists were poured into the swirling pool of the vortices. The 
diffusible species were trapped into the vortex region, thereby starting the circulatory 
transport. As time progressed even further, the vortex pool was gradually filled with 
agonists released from the thrombus surface, causing a significant rise in the agonist 
concentration. This interplay between the flow and aggregation process created an 
unexpected concentrated reservoir near the thrombus at the latter stage of clot 
development. Platelets that underwent circulatory motion during that time were exposed a 
region of concentrated activators. The pre-treatment with agonists can last for several 
seconds, therefore elevating the activation state of platelets even before the initiation of 
an aggregation event. There might even be formation of partial aggregate structure within 
the reactive pool due to accumulation of platelets. 
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Figure 4-6: Concentration field for ADP, TXA2, IIa for stenotic channel 
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4.5 Discussion 
A major theme of all multiscale modelling of platelet aggregation is the coupling of 
biological signaling, hemodynamics and mass transfer of proteins. It has been well 
recognized that platelet transport and binding kinetics all contribute the growth rate and 
morphology of thrombus.  Understanding the relation of the flow, aggregate buildup and 
activation dynamics is particularly important in establishing a numerical model toward 
visualizing the clotting processes within the stenotic coronary arteries that can potentially 
lead to serious episodes of myocardial infarction. Due to the vast difference in the cell 
size (3μm) and dimension of arteries (3mm in diameter), a fully particle-based simulation 
has proven to be arduous task. Previously, a multiscale model incorporating lattice 
Kinetic Monte Carlo (LKMC) for stochastic particle motion, lattice Boltzmann (LB) for 
hemodynamics, data-driven neural network (NN) for platelet calcium signaling was 
applied to simulate the real clotting processes within the microfluidic channel. [94] The 
platelet signaling kinetics was verified by microfluidic experiments and realized 
physiologically reasonable thrombus morphology. Extending the domain by 500 times, 
the current model was still able to achieve the particle-level resolution. The highly 
efficient LKMC algorithm was able to evolve a system of ~10000 particles under 
complex flow patterns. It is one of the first comprehensive models that can combine 
particle-level transport with complex enzyme signaling to realize the development of an 
arterial thrombosis extending a time domain of 10 minutes. The level of computational 
capacity cannot be achieved by other particle-based simulation techniques under similar 
resolution such as dissipative particle dynamics (DPD). 
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 The stenosis model recreated a coronary artery with symmetric stenosis and 
predicted platelet signaling and deposition based on spatiotemporal exposure to agonists 
in the event of a hypothetical rupture of vessel wall at the post-stenotic arc. Platelets that 
were attached collagen have sustained the calcium elevation. The strong thrombin field 
was found for the first several layers of deposited platelets which created the initial 
binding platform. The rate of thrombus formation was dependent on the platelet flux, 
biological signaling and collision efficiency. The stenotic geometry intensified the near-
wall concentration of particles as they travel through the narrowed channel. As particles 
traverse the hill of stenosis, strong convective field carries them downstream without 
having a chance to attack the reactive patch. The sharpness of the stenosis also reduced 
the probability of a platelet distant from the vessel wall to traverse the streamlines to 
clotting sites via enhanced diffusion by RBC. The trajectory test confirmed that only the 
near-wall platelets were able to contribute to the thrombus growth, consolidating the 
proposition of the two-phasic transport patterns in the presence of stenosis. The study of 
platelet trajectories also unveiled additional hitting mechanisms where some platelets 
underwent a tortuous path before attacking the backside of the thrombus bottom-up. At 
latter stage of clot formation, these platelets may be partially activated before reaching 
the clot mass. These platelets could be contributing additional signaling mechanisms 
beyond the scope of this model. 
While the rate of platelet deposition mainly depends on the hitting frequency of 
particles, the morphology of the clot is tightly regulated by the platelet signaling and 
prevailing wall shear conditions. The use of data-driven, activation dependent, shear-
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regulated attachment/detachment circumvents the need for expensive adhesive dynamics, 
correctly predicting thrombus morphology under venous shear condition consistent with 
microfluidic experiments. The presence of the stenosis created a high-shear region at the 
pre-stenotic segment while the shear condition stayed well within the low shear (<3000s
-1
) 
range at the backside, therefore similar rate kinetics should be expected. The occurrence 
of a protruding thrombus frontier accumulated near the top stenotic section is due to the 
existence of two different hitting dynamics. Again, hemodynamics strongly dictates the 
shape of the thrombus by forming a flow stagnation region with low convective field. 
The two hitting routes converge to this stagnation region where the binding kinetics is 
indirectly enhanced due to the relatively low convective force. The model was able to 
simulate the growth of the thrombus at relatively low shear conditions, which agreed well 
with microfluidic stenosis data.[80] The high-shear binding kinetics (>6000s
-1
) initiated 
by vWFs is yet to be concluded, that was considered to be important for inducing further 
platelet accumulation and causing complete vessel occlusion. 
The model provided a classical example of the interdependence of flow and 
aggregation. The growing thrombus altered the location of flow separation which led to a 
different transport dynamics. The model simulated the initiation of a well of concentrated 
species at the latter stage of clotting. The model clearly demonstrated that the switch 
from a localized agonist transport was due to the change in the flow patterns. This 
unexpected transport mechanism led to a concentrated whirlpool of reactive agonists that 
can in turn affect the growth dynamics of clotting as well. It also pinpointed that the 
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existence of flow stagnation would typically lead to a divergent transport pattern 
especially for particles in the vicinity of the critical separation line. 
 In summary, the numerical model was able to recreate the clotting process under 
complex stenotic flow conditions, which is one step closer toward the ultimate full 
simulation of thrombosis using patient-specific blood phenotypes in relevant arterial 
vasculatures. The numerical model had the potential of providing accurate prediction on 
the clotting process within the coronary artery where in vitro replication could be difficult. 
 
 
 
 
 
 
 
 
 
 
 
 
 
127 
 
Chapter 5 : Future work 
5.1 Model for fibrin polymerization 
Most of the kinetics leading to thrombin generation in the coagulation cascade is 
established under isotropic conditions. Much less is known about thrombin generation 
kinetics under flow conditions. Until recently, Zhu et al. measured thrombin released 
from clots using thrombin-antithrombin (TAT) immunoassay. [95] It was found (Figure 
5-1) that the majority (>85%) of generated thrombin was captured by intrathrombus 
fibrin as thrombin-antithrombin. Thrombin generation was undetectable downstream in 
the effluent unless Gly-Pro-Arg-Pro (GPRP) was added to block fibrin polymerization. 
With GPRP present, the flux of thrombin increased to ~0.5 × 10-12 nmol/μm
2
-s over the 
first 500 s of perfusion and then further increased by threefold over the next 300 s. The 
increased thrombin flux after 500 s was blocked by anti-FXIa antibody (O1A6), 
consistent with thrombin-feedback activation of FXI. Over the first 500 s, ~92,000 
molecules of thrombin were generated per surface TF molecule for the 250-μm-long 
coating. A single layer of platelets (obtained with αIIbβ3 antagonism preventing 
continued platelet deposition) was largely sufficient for thrombin production. 
The experimental measured thrombin flux was monotonic increasing in time with 
accelerated rate of increase in 500 s due to feedback activation of contact pathway. This 
observation is different from previously proposed flux function which is determined by 
isotropic kinetics.[29] Clearly, flow plays a significant role. However, little is known 
about the actual dynamics of the key precursors such as factor X, IX, V that can 
potentially cause this discrepancy. 
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One assumption is thrombin cleaves fibrinogen into fibrin, which may lead to decay in 
thrombin concentration as was observed in square-well experiments and numerical 
models. Fibrin could serve as a sink that consumes thrombin and limits the transport of 
thrombin, therefore reducing the effective thrombin flux. The Diamond lab recently has 
begun to quantify fibrin generation hoping to decipher the kinetics of thrombin-fibrin 
reaction in the presence of flow. The next step in numerical modeling of thrombosis is to 
introduce fibrin to the picture. The starting point will be to introduce a rectangular 
reaction zone near the collagen path that consumes most of the thrombin released from 
the wall. With the help of more microfluidic data on fibrin concentration, it will be 
possible to characterize the reaction between fibrin and thrombin. The presence of fibrin 
not only consumes thrombin, but also strengths the platelet activation signal and clot 
structure. These will ideally need to be accounted for in the numerical model as well. 
Finally, fibrin is not a diffusible protein like thrombin but more like fibrous polymer 
chain, which adds to the difficulty of developing a good representation for fibrin 
mechanisms. 
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Figure 5-1 Thrombin flux from clots growing on collagen/TF 
A, Dynamics of platelet aggregation (■) and fibrin formation (○) during CTI-treated (40 μg/mL) 
whole blood perfusion over collagen/high TF (1 molec/μm
2
) at initial wall shear rate of 200 s
-1
. B, 
Measured TAT concentration and thrombin flux during blood perfusion over collagen/high TF in 
the presence (○) and absence (■) of GPRP. C, TAT concentration and thrombin flux for TF 
surface concentration from 1 molec/μm
2 
(■) to 0.1 molec/μm
2
 (○). D, Averaged TAT 
concentration and thrombin flux from 13 healthy donors for blood perfusion (40 μg/mL CTI and 
5 mM GPRP) over collagen/high TF at 200 s
-1
. * p < 0.05, ** p <0.01.  
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5.2 Model for bleeding 
Bleeding could result from inactivation of platelets or acute injury. When bleeding occurs, 
blood is flowing through the clot into the surrounding tissue or air. The pressure drop 
between the blood and the interstitial fluid can be much larger than that across the 
thrombus in a sealed vessel. It will be necessary to consider the intra-thrombus pressure 
within the clot. The current model, the intra-thrombus transport is completely ignored, 
while in reality the blood clot is often porous, allowing trickles of flow passing through 
the clot. The LB solver has to be adapted for calculation of flow over porous media. 
Resolving flow on that level can be costly. In reality, platelets will transform into 
irregular shapes with large surface areas to increase contact with the collagen structures. 
For models, it is extremely to account for the idiosyncrasy of individual platelet size.   
A bleeding model is also likely to drastically change the initial dynamics of platelet 
aggregation. The pressure drop is likely to alter the clot morphology. A more suitable 
approach will be to use some mechanic models capturing the interactions between 
individual particles using force-based rules. Structure remodeling under large shear 
should be considered as well.  
5.3 Model for patients with coronary artery diseases 
The stenotic model described in Chapter 4 has laid the foundation for patient-specific 
simulation of coronary artery thrombosis. The next step will be to apply the model to 
study clot growth under pulsatile flow conditions. Here comes an immediate challenge: 
the computational fluid dynamic calculation of transient flow problems can be extremely 
costly. The computational capacity for a fully resolved patient cardio-vasculature with 
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optimized algorithms can only reach a time domain of a few seconds. The fully 3-D 
simulation with vortex features can be even more numerically prohibitive. Even a 2-D LB 
calculation with pulsatile boundary conditions is much more costly than quasi-steady 
flow. The single relaxation BGK operator will typically cause instability in the solution, 
therefore insufficient for complex flow problems.  More advanced LB solver should be 
adopted. 
In recent years, advances in numerical methods and three-dimensional imaging 
techniques have enabled the quantification of cardiovascular mechanics in subject-
specific anatomic and physiologic models. Patient-specific models are being used to 
guide cell culture and animal experiments and test hypotheses related to the role of 
biomechanical factors in vascular diseases. Furthermore, patient-specific modeling has 
enabled an entirely new application of cardiovascular mechanics, namely predicting 
outcomes of alternate therapeutic interventions for individual patients. [57] The current 
multiscale model can be applied to a representative coronary artery segment adapted from 
imaging of cardio-vasculature from patients and make predictions on platelet growth 
under physiological flow condition. It was also found that patients with coronary artery 
diseases have different platelet signaling functions. The Diamond lab has recently started 
to use high throughput screening to test the calcium response for patient blood. A new 
neural network specifically trained for patients is under development.  
One way to further the study is to transform the current 2D model to 3D to give a better 
approximation of the vessel geometry. There is no fundamental challenge to add another 
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dimension for all the numerical methods applied, however the computational cost could 
be interesting exponentially. Therefore, a lot of code optimization needs to be performed. 
5.4 Model optimization 
The current multi-element LKMC model combines four different modules where 
information exchange is frequent. The maintenance of the model has always been 
difficult as altering the formulation of one module can potentially affect other modules 
sometimes in unexpected ways. The complex coupling between modules also makes 
massive parallelism difficult although there have been well-stablished methods for 
parallel computation for algorithms like lattice Boltzmann. One alternative way is rewrite 
the modules to allow for parallel computing. Switching to commercially available 
software such as Palabos, OpenFOAM seems to be a necessity. Finite element solvers 
also need to be upgraded to handle even more complex pulsatile transient flow patterns.  
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Chapter 6 : Time course of simulation 
Constant flow simulation 
 
Figure 6-1: Multiscale simulation of platelet deposition under constant flow mode at 1 sec 
Platelet activation (black unactivated, white-activated) and deposition (under constant flow rate 
with initial wall shear of 200 sec
-1
). Flow: left to right (streamlines indicated as thin black lines); 
Surface collagen (250 μm long): red bar. 
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Figure 6-2: Multiscale simulation of platelet deposition under constant flow mode at 100 sec. 
Platelet activation (black unactivated, white-activated) and deposition (under constant flow rate 
with initial wall shear of 200 sec
-1
). Flow: left to right (streamlines indicated as thin black lines); 
Surface collagen (250 μm long): red bar. 
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Figure 6-3: Multiscale simulation of platelet deposition under constant flow mode at 200 sec. 
Platelet activation (black unactivated, white-activated) and deposition (under constant flow rate 
with initial wall shear of 200 sec
-1
). Flow: left to right (streamlines indicated as thin black lines); 
Surface collagen (250 μm long): red bar. 
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Figure 6-4: Multiscale simulation of platelet deposition under constant flow mode at 300 sec. 
Platelet activation (black unactivated, white-activated) and deposition (under constant flow rate 
with initial wall shear of 200 sec
-1
). Flow: left to right (streamlines indicated as thin black lines); 
Surface collagen (250 μm long): red bar. 
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Figure 6-5: Multiscale simulation of platelet deposition under constant flow mode at 400 sec. 
Platelet activation (black unactivated, white-activated) and deposition (under constant flow rate 
with initial wall shear of 200 sec
-1
). Flow: left to right (streamlines indicated as thin black lines); 
Surface collagen (250 μm long): red bar. 
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Pressure relief simulation 
 
Figure 6-6: Multiscale simulation of platelet deposition under pressure relief mode at 1 sec. 
Platelet activation (black unactivated, white-activated) and deposition (under constant flow rate 
with initial wall shear of 200 sec
-1
). Flow: left to right (streamlines indicated as thin black lines); 
Surface collagen (250 μm long): red bar. 
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Figure 6-7: Multiscale simulation of platelet deposition under pressure relief mode at 100 sec. 
Platelet activation (black unactivated, white-activated) and deposition (under constant flow rate 
with initial wall shear of 200 sec
-1
). Flow: left to right (streamlines indicated as thin black lines); 
Surface collagen (250 μm long): red bar. 
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Figure 6-8: Multiscale simulation of platelet deposition under pressure relief mode at 200 sec. 
Platelet activation (black unactivated, white-activated) and deposition (under constant flow rate 
with initial wall shear of 200 sec
-1
). Flow: left to right (streamlines indicated as thin black lines); 
Surface collagen (250 μm long): red bar. 
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Figure 6-9: Multiscale simulation of platelet deposition under pressure relief mode at 300 sec. 
Platelet activation (black unactivated, white-activated) and deposition (under constant flow rate 
with initial wall shear of 200 sec
-1
). Flow: left to right (streamlines indicated as thin black lines); 
Surface collagen (250 μm long): red bar. 
 
 
142 
 
 
Figure 6-10: Multiscale simulation of platelet deposition under pressure relief mode at 400 sec. 
Platelet activation (black unactivated, white-activated) and deposition (under constant flow rate 
with initial wall shear of 200 sec
-1
). Flow: left to right (streamlines indicated as thin black lines); 
Surface collagen (250 μm long): red bar. 
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